{
  "meta": {
    "id": "test22",
    "title": "Medicine - NEET PG 2024",
    "category": "NEET PG PYQ"
  },
  "questions": [
    {
      "text": "A 30-year-old patient came with chest pain, shortness of breath, and pedal edema. JVP showed rapid y descent. On auscultation, he had a high-pitched diastolic sound. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic constrictive pericarditis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cardiac tamponade",
          "correct": false
        },
        {
          "label": "C",
          "text": "RHD with Mitral stenosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bicuspid aortic valve with Aortic regurgitation",
          "correct": false
        }
      ],
      "correct_answer": "A. Chronic constrictive pericarditis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Chronic constrictive pericarditis Chronic constrictive pericarditis is the most likely diagnosis based on the patient's symptoms of chest pain, shortness of breath, and pedal edema, along with the physical findings of rapid Y descent on JVP and a high-pitched diastolic sound. These findings are characteristic of the condition, which is caused by inflammation and scarring of the pericardium, leading to restricted heart movement and impaired diastolic filling.</p>\n<p><strong>Highyeild:</strong></p><p>Constrictive pericarditis is a condition resulting from the thickening and fibrosis of the pericardium, which restricts the heart's ability to fill properly during diastole. Patients often present with symptoms of heart failure, such as exertional dyspnea, orthopnea, and lower extremity edema. Physical examination typically reveals elevated jugular venous pressure (JVP) with a prominent \"y\" descent, reflecting rapid diastolic filling followed by a sudden decrease due to restricted ventricular expansion. A pericardial knock, an early diastolic sound, may be auscultated, indicating abrupt cessation of ventricular filling. Pulsus paradoxus (a drop in blood pressure during inspiration) can be observed. On imaging, echocardiography shows pericardial thickening, and Doppler studies may reveal impaired diastolic function with characteristic septal bounce. Cardiac MRI or CT can provide detailed visualization of pericardial thickening and help differentiate constrictive pericarditis from restrictive cardiomyopathy. In severe cases, treatment involves diuretics to alleviate symptoms and pericardiectomy to remove the fibrotic pericardium, restoring normal cardiac function.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Cardiac tamponade: While cardiac tamponade can also present with chest pain, shortness of breath, and pedal edema, it typically has a more acute onset and often involves a rapid accumulation of fluid in the pericardial space. The JVP would typically show a flattened Y descent due to the inability of the right atrium to empty properly. Option: C. RHD with mitral stenosis: Mitral stenosis is characterized by a diastolic murmur, not a pericardial knock. Additionally, the JVP would typically show a V wave due to the backflow of blood into the right atrium. Option: D. Bicuspid aortic valve with aortic regurgitation: Aortic regurgitation typically presents with a diastolic murmur and a wide pulse pressure. The JVP would not be expected to have a rapid Y descent.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Abnormalities of JVP waveforms:- Waveform Cardiac Condition Absent a wave Atrial fibrillation, sinus tachycardia Flutter waves Atrial flutter Prominent a waves First-degree atrioventricular block Large a waves Tricuspid stenosis, right atrial myxoma, pulmonary hypertension, pulmonic stenosis Cannon a waves Atrioventricular dissociation, ventricular tachycardia Absent x descent Tricuspid regurgitation Prominent x descent Conditions causing enlarged a waves Large cv waves Tricuspid regurgitation, constrictive pericarditis Slow y descent Tricuspid stenosis, right atrial myxoma Rapid y descent Constrictive pericarditis, severe right heart failure, tricuspid regurgitation, atrial septal defect Absent y descent Cardiac tamponade Cardiac tamponade Vs Constrictive Pericarditis:- Cardiac tamponade CP Fixed cardiac volume limiting cardiac filling \u2191 respiratory variation of ventricular filling Fixed cardiac volume limiting cardiac filling \u2191  respiratory variation of ventricular filling Ventricular interdependence (septal shift) Ventricular interdependence (septal shift) Elevated and equalized central venous, pulmonary venous and ventricular diastolic pressures Elevated and equalized central venous, pulmonary venous and ventricular diastolic pressures Prominent systolic filling (attenuated Y descent) Prominent early diastolic filling (exaggerated Y descent) Inspiratory \u2193 in intrathoracic pressure not transmitted to heart (dissociation of intracardiac and intrathoracic pressures) Inspiratory \u2193 in intrathoracic pressure not transmitted to heart (dissociation of intracardiac and intrathoracic pressures) Pulsus paradoxus common Pulsus paradoxus uncommon Kussmaul's sign not present Kussmaul's sign</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd1ecc84",
      "audio": ""
    },
    {
      "text": "A 30-year-old female patient comes to the outpatient department with complaints of neck swelling. She gives a history of weight loss and palpitations. On examination, she has exophthalmos and a diffusely enlarged thyroid gland. Which of the following is not true?",
      "options": [
        {
          "label": "A",
          "text": "Severe disease can cause vision loss",
          "correct": false
        },
        {
          "label": "B",
          "text": "NO SPECS criteria is used for this condition",
          "correct": false
        },
        {
          "label": "C",
          "text": "10% of isolated cases are present without hyperthyroidism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Condition will improve simultaneously with improvement in thyrotoxic state",
          "correct": true
        }
      ],
      "correct_answer": "D. Condition will improve simultaneously with improvement in thyrotoxic state",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Condition will improve simultaneously with improvement in thyrotoxic state Condition will improve simultaneously with improvement in thyrotoxic state. This is incorrect because thyroid eye disease (TED) does not improve concurrently with the resolution of hyperthyroidism; it often requires separate management.</p>\n<p><strong>Highyeild:</strong></p><p>Graves' disease is an autoimmune disorder that causes hyperthyroidism, characterized by the overproduction of thyroid hormones due to thyroid-stimulating immunoglobulins (TSI) that stimulate the thyroid gland. It is the most common cause of hyperthyroidism, typically presenting with symptoms such as weight loss, palpitations, increased appetite, heat intolerance, sweating, fatigue, and diarrhea. The physical examination often reveals a diffusely enlarged thyroid gland (goiter), tachycardia, tremors, and, in older patients, atrial fibrillation. A significant complication of Graves' disease is thyroid eye disease (TED), also known as Graves' ophthalmopathy, which affects approximately one-third of patients with the condition. TED is characterized by inflammation and swelling of the extraocular muscles and surrounding tissues, leading to symptoms like exophthalmos (protrusion of the eyes), diplopia (double vision), and visual impairment due to optic nerve compression in severe cases. The condition is often graded using the NO SPECS classification system, which assesses the severity based on symptoms and signs, ranging from no signs or symptoms to severe vision-threatening complications. The pathophysiology of TED involves an autoimmune process similar to that of Graves' disease, where TSI also targets the retro-orbital space, leading to inflammation and edema. The specific trigger for the development of TED is not fully understood but is thought to involve a combination of genetic predisposition and environmental factors, including smoking, which significantly increases the risk and severity of the disease.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Severe disease can cause vision loss: Severe cases of thyroid eye disease (TED) can lead to compression of the optic nerve, resulting in vision loss. Option: B. NO SPECS criteria is used for this condition: The NO SPECS classification system is used to assess the severity of thyroid eye disease. Option: C. 10% of isolated cases are present without hyperthyroidism: Some patients may have thyroid eye disease without overt hyperthyroidism, a condition known as euthyroid Graves' disease.</p>\n<p><strong>Extraedge:</strong></p><p>Signs of Graves' Ophthalmopathy:- Sign Description Exophthalmos Protrusion of the eyeballs due to swelling of retro-orbital tissues Dalrymple's Sign Lid retraction leading to a wide-eyed appearance; the upper eyelid is elevated Von Graefe's Sign Lid lag when the patient looks down; the upper eyelid lags behind the movement of the globe Kocher's Sign Inability to close the eyelids completely due to lid retraction; may result in corneal exposure Thyroid Bruits Audible bruits over the thyroid gland, indicating increased vascularity (less directly an eye sign) M\u00fcller's Sign Upper eyelid retraction seen when the patient is asked to look up</p>\n<p><strong>Table:</strong></p><p>#MANTRA Graves\u2019 Disease algorithm:</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7be9c6c0",
      "audio": ""
    },
    {
      "text": "A 56-year-old presented with fever, chills & cough with sputum. Blood pressure was measured to be 150/88 mmhg, pulse rate - 110 bpm and respiratory rate - 18, spo2 - 88% at room air. X-ray was done and shown below. What is the probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Tubercular pleural effusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Community acquired pneumonia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Coal worker Pneumoconiosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Silicosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Community acquired pneumonia",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183236500-QT30IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Community acquired pneumonia The most probable diagnosis for this 56-year-old patient presenting with fever, chills, cough with sputum, hypoxemia (SpO2 88% at room air), elevated pulse rate (110 bpm), and acute respiratory distress is community-acquired pneumonia (CAP). The x-ray also confirms it because of the consolidation seen on it. This condition typically presents with acute respiratory symptoms and may lead to hypoxia, aligning with the patient\u2019s clinical picture.</p>\n<p><strong>Highyeild:</strong></p><p>Community-Acquired Pneumonia (CAP) is an infection of the lungs acquired outside of a hospital or healthcare setting. It is a common condition that can affect individuals of all ages but is particularly serious in the elderly and those with underlying health issues. Etiology- CAP can be caused by various pathogens, including: Bacteria: The most common bacterial cause is Streptococcus pneumoniae. Other notable bacteria include Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila. Viruses: Common viral causes include influenza virus, respiratory syncytial virus (RSV), and coronaviruses. Fungi: In immunocompromised patients, fungi like Histoplasma or Coccidioides may cause pneumonia. Pathophysiology- Infection occurs when pathogens enter the lungs, leading to inflammation of the alveoli (air sacs). This inflammation can result in the accumulation of fluid and pus, impairing gas exchange and leading to symptoms of respiratory distress. Clinical Presentation Patients with CAP typically present with: Symptoms: Cough (may produce sputum), fever, chills, pleuritic chest pain, dyspnea, fatigue, and malaise. Signs: Elevated respiratory rate, tachycardia, hypoxemia (reduced oxygen saturation), and abnormal lung sounds (such as crackles or bronchial breath sounds) on auscultation. Diagnosis is based on clinical evaluation and may include: History and Physical Examination: Assessment of symptoms and vital signs. Chest X-ray: To identify areas of consolidation or infiltrates in the lungs. Laboratory Tests: Blood tests (e.g., complete blood count) may show leukocytosis. Sputum cultures can help identify the causative organism, although they are not always necessary. Rapid Antigen Testing: For certain pathogens like influenza or pneumococcus can aid in diagnosis. Treatment Management of CAP involves: Antibiotics: Empirical treatment should be initiated promptly. Common first-line antibiotics for outpatient treatment include azithromycin or doxycycline. For hospitalized patients, options may include ceftriaxone combined with azithromycin or respiratory fluoroquinolones. Supportive Care: Oxygen therapy for hypoxemia, fluid management, and symptomatic relief (antipyretics, cough suppressants). Vaccination: Vaccines against influenza and pneumococcus are recommended to prevent CAP, particularly in high-risk groups.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Tubercular pleural effusion presents with a more chronic history of cough, weight loss, and night sweats, rather than acute fever and chills. While pleural effusion can cause hypoxemia, the acute presentation here is more indicative of pneumonia. Option: C. Coal worker pneumoconiosis is an occupational lung disease that develops over years of exposure to coal dust. Patients usually present with a chronic cough and respiratory symptoms, often accompanied by progressive dyspnea, rather than an acute febrile illness. Acute respiratory distress is not typical in early stages. Option: D. Silicosis is a chronic condition that occurs due to long-term exposure to silica dust. Symptoms typically develop over years and include a chronic cough and shortness of breath, not acute fever and chills.</p>\n<p><strong>Extraedge:</strong></p><p>CURB-65 Score for Pneumonia:- Factor Points Confusion I Blood urea nitrogen > 19 mg/dL I Respiratory rate \u2265 30 breaths per minute I Systolic blood pressure < 90 mm Hg or diastolic blood pressure \u2264 60 mm Hg I Age \u2265 65 years I CURB-65  Score Mortality Risk (%) Recommendation 0 o.6 Low risk; consider outpatient treatment 1 2.7 Low risk; consider outpatient treatment 2 6.8 Short inpatient or outpatient treatment with close observation 3 14 Inpatient; consider intensive care unit 4 or 5 27.8 Inpatient; consider intensive care unit</p>\n<p><strong>Table:</strong></p><p>#MANTRA Feature Tubercular Pleural Effusion Community-Acquired Pneumonia (CAP) Coal Worker Pneumoconiosis Silicosis Etiology Mycobacterium tuberculosis Various pathogens, primarily bacteria (e.g., Streptococcus pneumoniae) Prolonged exposure to coal dust Prolonged exposure to silica dust Symptoms Cough, pleuritic chest pain, fever, weight loss Cough, fever, chills, sputum production, dyspnea Chronic cough, progressive dyspnea Chronic cough, progressive dyspnea Signs Dullness on percussion, decreased breath sounds, pleuritic rub Tachypnea, tachycardia, abnormal lung sounds (crackles) Crackles or wheezing on auscultation; signs of respiratory failure in advanced cases Crackles on auscultation; may develop respiratory failure Imaging Chest X-ray shows pleural effusion; may show signs of TB Chest X-ray shows consolidation or infiltrates X-ray shows small opacities (nodular shadows) X-ray shows small rounded opacities (eggshell calcifications) Diagnosis Pleural fluid analysis (elevated lymphocytes, AFB smear, culture) Clinical assessment, sputum culture, chest X-ray Occupational history, chest X-ray Occupational history, chest X-ray Treatment Antitubercular therapy (e.g., rifampicin, isoniazid) Antibiotics (empirical therapy based on severity) No cure; supportive care; management of respiratory symptoms No cure; supportive care; management of respiratory symptoms</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2b973c31",
      "audio": ""
    },
    {
      "text": "A 45-year-old man presented with fatigue and hemoptysis. His current hemoglobin is 8g/dL (previous hemoglobin one week ago was 12 g/dL). His bronchoalveolar lavage is reddish and his serum creatinine was 1.7mg/dL. He is diagnosed with ANCA-positive glomerulonephritis. Biopsy of the kidney revealed pauci-immune deposits and the absence of granulomas. Which of the following conditions is he likely suffering from?",
      "options": [
        {
          "label": "A",
          "text": "Churg-Strauss Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Microscopic Polyangiitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "SLE",
          "correct": false
        },
        {
          "label": "D",
          "text": "Henoch-Schonlein Purpura",
          "correct": false
        }
      ],
      "correct_answer": "B. Microscopic Polyangiitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Microscopic Polyangiitis The most likely condition for this 45-year-old man presenting with fatigue, hemoptysis, significant anemia (hemoglobin dropping from 12 g/dL to 8 g/dL), reddish bronchoalveolar lavage, elevated serum creatinine (1.7 mg/dL), and diagnosed with ANCA-positive glomerulonephritis, is microscopic polyangiitis. This condition is characterized by renal involvement with pauci-immune glomerulonephritis, respiratory symptoms like hemoptysis, and a lack of granulomas on biopsy, which aligns with the patient's findings.</p>\n<p><strong>Highyeild:</strong></p><p>Microscopic Polyangiitis (MPA) is a small-vessel vasculitis characterized by the inflammation of small blood vessels, particularly affecting the kidneys and lungs. It is associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA), specifically myeloperoxidase-ANCA (MPO-ANCA). Clinically, MPA often presents with rapidly progressive glomerulonephritis, leading to renal failure, and pulmonary symptoms, including hemoptysis due to alveolar hemorrhage. Patients may also experience constitutional symptoms such as fever, malaise, and weight loss. Unlike other forms of vasculitis, MPA typically lacks granulomatous inflammation on biopsy, showing pauci-immune glomerular deposits instead. Diagnosis involves a combination of clinical assessment, serological testing for ANCA, and kidney biopsy. Treatment primarily consists of corticosteroids and immunosuppressive agents, such as cyclophosphamide or rituximab, aimed at inducing remission and preventing disease progression. Early diagnosis and aggressive management are crucial for improving outcomes, particularly concerning renal function. Classification of Vasculitis</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Churg-Strauss syndrome (now called eosinophilic granulomatosis with polyangiitis) usually presents with asthma and eosinophilia, along with granulomatous inflammation, which does not fit this case. Option: C. Systemic lupus erythematosus (SLE) can cause hemoptysis and renal involvement but is often associated with immune complex deposits rather than pauci-immune patterns. Option: D. Henoch-Schonlein purpura primarily presents with a tetrad of symptoms (purpura, arthralgia, abdominal pain, and renal involvement) and is more common in children, often with IgA deposition.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4fb824d",
      "audio": ""
    },
    {
      "text": "A patient with an acute exacerbation of COPD required mechanical ventilation and experienced a consistent drop in oxygen saturation. Auscultation revealed vesicular breath sounds on the right side. Based on the chest radiography findings, what would you expect to hear on auscultation of the left side?",
      "options": [
        {
          "label": "A",
          "text": "Absent Breath Sounds",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bronchial Breath Sounds",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased Vesicular Breath Sounds",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased Vocal Fremitus",
          "correct": false
        }
      ],
      "correct_answer": "A. Absent Breath Sounds",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183236605-QT45IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Absent Breath Sounds In this scenario, where a patient with an acute exacerbation of COPD experiences a drop in oxygen saturation and has vesicular breath sounds on the right side, the expected auscultation findings on the left side would likely be absent breath sounds. This is indicative of significant pathology, such as consolidation, pleural effusion or collapse, affecting lung ventilation. The absence of breath sounds on the left reflect reduced air entry due to lung collapse as has been shown by the x-ray.</p>\n<p><strong>Highyeild:</strong></p><p>Lung collapse, or atelectasis, occurs when alveoli (the tiny air sacs in the lungs) collapse or do not inflate properly. This can result from various causes, including: Obstructive Atelectasis: Blockage of airways due to mucus plugs, foreign bodies, or tumors prevents air from reaching certain areas of the lung. Non-obstructive Atelectasis : Can occur due to factors such as shallow breathing (often seen in postoperative patients), pleural effusion (fluid accumulation), or pneumothorax (air in the pleural space). Pneumothorax specifically refers to the presence of air in the pleural cavity, which can occur spontaneously or due to trauma. It leads to increased pressure in the pleural space, causing the lung on the affected side to collapse. Auscultation Findings Auscultation is a crucial clinical skill used to assess lung sounds and overall respiratory function. The presence or absence of breath sounds can provide valuable information about lung status. Here's how lung collapse affects auscultation: Affected Side (Collapsed Lung): Absent Breath Sounds: On the side of the lung collapse, breath sounds are often absent or significantly diminished. This lack of sound occurs because air cannot reach the alveoli for normal gas exchange, leading to reduced airflow. Increased Resonance: If the collapse is due to pneumothorax, there may be hyper-resonance during percussion, indicating trapped air. Contralateral Side (Uncollapsed Lung): Vesicular Breath Sounds: Normal breath sounds should still be present on the side that is not affected, as airflow continues to the lung that remains inflated. Possible Changes: In cases where the mediastinum shifts (such as with tension pneumothorax), abnormal findings could be noted. Pathophysiological Mechanisms When a lung collapses: Ventilation-perfusion mismatch occurs, leading to impaired gas exchange, which can result in decreased oxygen saturation and respiratory distress. The body may try to compensate for the collapse by increasing respiratory rate or using accessory muscles for breathing. Recognizing the signs of lung collapse is critical for appropriate management . For instance: Management of Atelectasis: Includes incentive spirometry, deep breathing exercises, and sometimes bronchoscopy to clear obstructions. Management of Pneumothorax: May involve needle decompression or chest tube insertion to remove air and allow the lung to re-expand.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Bronchial breath sounds might occur if there\u2019s consolidation, but this is unlikely with a simple collapse. Option: C. Increased vesicular breath sounds would indicate improved airflow or consolidation, which is not consistent with a collapsed lung. Option: D. Increased vocal fremitus is often associated with lung consolidation (e.g., pneumonia), not with a collapsed lung.</p>\n<p><strong>Extraedge:</strong></p><p>Management of COPD:- stage Recommended Treatment All \u25cf       Avoidance of risk factors (eg, smoking). \u25cf       Influenza vaccine annually. \u25cf       Pneumococcal polysaccharide vaccine. \u25cf       Treatment of complications. Mild COPD \u25cf       Short-acting bronchodilator when needed. Moderate COPD \u25cf       Regular treatment with one or more bronchodilator. \u25cf       Rehabilitation. Severe COPD \u25cf       Regular treatment with one or more bronchodilator. \u25cf       Inhaled corticosteroids for patients with repeated exacerbation or persistent symptoms despite bronchodilator therapy.. \u25cf       Rehabilitation. Very Severe COPD \u25cf       Regular treatment with one or more bronchodilator. \u25cf       Inhaled corticosteroids if symptoms persist despite bronchodilator therapy. \u25cf       Rehabilitation. \u25cf       Long term 02 therapy if chronic respiratory failure. \u25cf       Surgical treatments considered.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Complications of COPD:- Respiratory insufficiency Respiratory failure Pneumonia Atelectasis Pneumothorax Pulmonary artery hypertension Status asthmaticus Hypoxemia Respiratory infections, including colds, flu Heart problems Lung cancer</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c28a7ebc",
      "audio": ""
    },
    {
      "text": "A patient with salicylic acid poisoning has the following arterial blood gas analysis report: pH = 7.3, pCO2 =16mmHg, HCO3-=6.3mmol/L, Na+- 135, K+- 4.5 CI-113.7, lactate was normal. Which of the following options correctly describes the condition?",
      "options": [
        {
          "label": "A",
          "text": "Metabolic acidosis with partial compensated respiratory alkalosis with high anion gap",
          "correct": true
        },
        {
          "label": "B",
          "text": "Respiratory acidosis with compensatory metabolic alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metabolic acidosis with uncompensated respiratory alkalosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Respiratory acidosis with metabolic alkalosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Metabolic acidosis with partial compensated respiratory alkalosis with high anion gap",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Metabolic acidosis with partial compensated respiratory alkalosis with high anion gap The arterial blood gas analysis of the patient with salicylic acid poisoning shows metabolic acidosis with a pH of 7.3 and a low bicarbonate level of 6.3 mmol/L, indicating significant acid-base disturbance. The low pCO2 of 16 mmHg suggests respiratory compensation through hyperventilation, although the acidosis is not fully compensated since the pH remains below normal. Additionally, the condition is consistent with a high anion gap, typical in salicylate toxicity due to the accumulation of unmeasured anions. Therefore, the correct interpretation is metabolic acidosis with partial compensated respiratory alkalosis and high anion gap.</p>\n<p><strong>Highyeild:</strong></p><p>Metabolic acidosis is a clinical condition characterized by a decrease in blood pH due to an excess of hydrogen ions (H\u207a) or a loss of bicarbonate (HCO\u2083\u207b). It can result from various underlying causes, broadly categorized into increased acid production, decreased acid excretion, or loss of bicarbonate. Common etiologies include diabetic ketoacidosis, renal failure, lactic acidosis, and gastrointestinal loss of bicarbonate (e.g., diarrhea). In metabolic acidosis, the arterial blood gas analysis typically shows a low pH (less than 7.35) and a decreased bicarbonate level (less than 22 mmol/L). The body attempts to compensate for metabolic acidosis through respiratory mechanisms, primarily hyperventilation, which reduces carbon dioxide (CO\u2082) levels (respiratory alkalosis), thereby helping to raise the pH. The anion gap, calculated from serum electrolytes, is often used to differentiate the causes of metabolic acidosis; a high anion gap indicates the presence of unmeasured anions, while a normal anion gap suggests a loss of bicarbonate without a corresponding increase in acids. Clinical manifestations may include fatigue, confusion, deep and rapid breathing (Kussmaul respirations), and in severe cases, shock or coma. Management focuses on treating the underlying cause, correcting the acid-base imbalance, and in severe cases, administering bicarbonate to raise the pH. HAGMA NAGMA Renal failure latrogenic: \u25cf       Saline \u25cf       Parenteral nutrition \u25cf       Carbonic anhydrase inhibitors Ketoacidosis: \u25cf       Diabetic \u25cf       Alcoholic \u25cf       Starvation Renal losses: \u25cf       Renal tubular acidosis \u25cf       Uretoenterostomy Lactic acidosis GI losses: \u25cf       Diarrhoea \u25cf       Small bowel/pancreatic drainage Toxins: \u25cf       Methanol \u25cf       Ethylene glycol \u25cf       Salicylates \u25cf       Metformin \u25cf       Pyroglutamic acid</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Respiratory acidosis with compensatory metabolic alkalosis suggests that the primary issue is respiratory acidosis, which is characterized by a high pCO2 and low pH. However, in this case, the pCO2 is low (16 mmHg), indicating hyperventilation rather than hypoventilation, which rules out respiratory acidosis. Option: C. Metabolic acidosis with uncompensated respiratory alkalosis correctly identifies the metabolic acidosis, it states that the respiratory alkalosis is uncompensated. The low pCO2 indicates that the patient is hyperventilating in response to the acidosis, showing respiratory compensation. Therefore, it is not uncompensated. Option: D. Respiratory acidosis with metabolic alkalosis implies a primary respiratory acidosis with elevated pCO2 and compensatory metabolic alkalosis. Since the pCO2 is low and the bicarbonate is also low, it cannot be classified as respiratory acidosis or metabolic alkalosis.</p>\n<p><strong>Table:</strong></p><p>#MANTRA ABG Interpretation:- 1\u00b0 DISORDER PH P a CO 2 [HCO 3 - ] COMPENSATION AG/non-AG Metabolic Acidosis \u2193 \u2193(2\u00b0) \u2193(1\u00b0) P a CO 2 , expect = 1.5 [HCO 3 - ] + 8 \u00b1 2 If P a CO 2 , actual < P a CO 2 , expect also 1\u00ba respiratory alkalosis If P a CO 2 , actual > P a CO 2 , expect also 1\u00ba respiratory acidosis AG Acidosis \"Delta/Delta\" For AG metabolic acidosis, calculate \u0394 AG /\u0394[HCO 3 - ] = (AG-12)/ (24- [HCO 3 - ]) if < 0.8, non-AG acidosis; if > 2, metabolic alkalosis Metabolic Alkalosis \u2191 \u2191(2\u00b0) \u2191(1\u00b0) P a CO 2 = 0.7 x [HCO 3 - ] + 20 \u00b1 5 If P a CO 2 , actual < P a CO 2 , expect also 1\u00ba respiratory alkalosis If P a CO 2 , actual > P a CO 2 , expect also 1\u00ba respiratory acidosis Respiratory Acidosis \u2193 \u2191(1\u00b0) \u2191(2\u00b0) For each\u2191 10 mmHg in PaCO2 Acute:\u2191 [HCO 3] 1 mmol/L and \u2193 pH 0.08 Chronic: \u2191 [HCO 3] 4 mmol/L and \u2193 pH 0.03 Respiratory Alkalosis \u2191 \u2193(1\u00b0) \u2193(2\u00b0) For each \u219310 mmHg in P CO2 a Acute:\u2193 [HCO 3] 2 mmol/L and \u2191 pH 0.08 Chronic:\u2193 [HCO 3] 5 mmol/L and \u2191 pH 0.03 Primary disorder (1\u00b0), compensation (2\u00b0); arrows relative to \"normal\" baseline values: pH 7.35-7.45, P a CO 2 35-45 mmHg and [HCO 3 - ] 22-26 mEq/L</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9981a2b3",
      "audio": ""
    },
    {
      "text": "Match the following ECG waves with condition: atrial flutter, atrial fibrillation, SVT, ventricular tachycardia : Select the correct answer from the given below code:",
      "options": [
        {
          "label": "A",
          "text": "1-ii, 2-i, 3-iv, 4-iii",
          "correct": true
        },
        {
          "label": "B",
          "text": "1-ii, 2-i, 3-iii, 4-iv",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-i, 2-ii, 3-iii, 4-iv",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-ii, 2-iv, 3-1, 4-iii",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-ii, 2-i, 3-iv, 4-iii",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183236687-QT60IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>1-ii, 2-i, 3-iv, 4-iii The correct match of the arrhythmias is as- 1-Atrial flutter 2-Atrial fibrillation 3 -Ventricular tachycardia 4-SVT</p>\n<p><strong>Highyeild:</strong></p><p>Feature Atrial Flutter Atrial Fibrillation Supraventricular Tachycardia (SVT) Ventricular Tachycardia (VT) Rate Typically 240-340 bpm Irregularly irregular, often 100-175 bpm 150-250 bpm 100-250 bpm (can vary) Rhythm Regularly irregular (often \"sawtooth\" pattern) Irregularly irregular Regular (can be irregular) Regular or irregular P Waves Present, \"sawtooth\" appearance (F-waves) Absent or chaotic Absent (but may see retrograde P waves) Absent or not discernible QRS Complex Usually narrow (unless associated with bundle branch block) Usually narrow (if not pre-existing BBB) Usually narrow Usually wide (> 0.12 seconds) Causes Often structural heart disease, pulmonary disease Hypertension, heart disease, hyperthyroidism Can be triggered by stimulants, stress, or heart disease Ischemic heart disease, cardiomyopathy Symptoms Palpitations, shortness of breath, fatigue Palpitations, fatigue, dizziness, risk of stroke Palpitations, dizziness, chest pain Palpitations, dizziness, syncope, chest pain Management Rate control, rhythm control, catheter ablation Anticoagulation, rate/rhythm control, cardioversion Vagal maneuvers, beta-blockers, adenosine Antiarrhythmic drugs, cardioversion, ICD placement Risk of Thromboembolism Moderate risk (more than normal sinus rhythm) High risk (especially if persistent) Low risk Variable, depending on underlying condition</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option B: This option is incorrect because SVT; Ventricular tachycardia Option C: This option is incorrect because Atrial flutter; Atrial fibrillation;\\ SVT; Ventricular tachycardia Option D: This option is incorrect because Atrial fibrillation; Atrial flutter;</p>\n<p><strong>Table:</strong></p><p>#MANTRA Arrhythmias:-</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "48a7604e",
      "audio": ""
    },
    {
      "text": "A 34-year-old patient presents with lethargy and tiredness. On examination, he has perioral hyperpigmentation. His blood pressure is 90/60 mmHg and his heart rate is 110 beats/minute. Laboratory investigations revealed Na+ of 125mEq/L and K+ of 5.5mEq/L. What is the most appropriate treatment given to this patient?",
      "options": [
        {
          "label": "A",
          "text": "ACTH",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hydrocortisone + Fludrocortisone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dexamethasone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Saline infusion",
          "correct": false
        }
      ],
      "correct_answer": "B. Hydrocortisone + Fludrocortisone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hydrocortisone + Fludrocortisone The 34-year-old patient exhibits signs of adrenal insufficiency, including lethargy, perioral hyperpigmentation, low blood pressure (90/60 mmHg), tachycardia (heart rate of 110 bpm), hyponatremia (Na+ of 125 mEq/L), and hyperkalemia (K+ of 5.5 mEq/L). The most appropriate treatment is hydrocortisone + fludrocortisone, which provides both glucocorticoid and mineralocorticoid replacement to address the adrenal hormone deficiencies and correct the electrolyte imbalances, thus stabilizing blood pressure and overall health.</p>\n<p><strong>Highyeild:</strong></p><p>Adrenal insufficiency is a condition characterized by inadequate production of hormones from the adrenal glands, leading to various physiological disturbances. It can be classified into three main types: primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency, and tertiary adrenal insufficiency. Primary adrenal insufficiency results from autoimmune destruction of the adrenal cortex, although it can also be caused by infections (e.g., tuberculosis), adrenal hemorrhage, or metastatic cancer. In this type, both cortisol and aldosterone production are deficient, affecting glucose metabolism, electrolyte balance, and the body's ability to respond to stress. Secondary adrenal insufficiency occurs due to inadequate production of adrenocorticotropic hormone (ACTH) by the pituitary gland, often resulting from pituitary tumors or prolonged use of glucocorticoids that suppress ACTH secretion. In this case, cortisol levels are primarily affected, while aldosterone production may remain normal due to regulation by the renin-angiotensin system. Tertiary adrenal insufficiency results from a lack of corticotropin-releasing hormone (CRH) from the hypothalamus, usually due to prolonged glucocorticoid therapy, and presents similarly to secondary adrenal insufficiency. Common symptoms of adrenal insufficiency include fatigue, weakness, weight loss, decreased appetite, hyperpigmentation of the skin (especially in primary adrenal insufficiency), hypotension, hyperkalemia, hyponatremia, nausea, vomiting, abdominal pain, and mood changes. In severe cases, patients may experience an adrenal crisis, a life-threatening condition characterized by severe hypotension, shock, and altered mental status.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. ACTH would stimulate the adrenal glands to produce cortisol, but in this case, the patient likely has primary adrenal insufficiency (Addison's disease), where the adrenal glands are unable to respond appropriately to ACTH due to damage. Therefore, administering ACTH does not address the immediate need for cortisol replacement. Option: C. Dexamethasone is a potent glucocorticoid but has no mineralocorticoid activity. In patients with adrenal insufficiency, especially with low blood pressure and electrolyte imbalances, it is crucial to provide both glucocorticoid and mineralocorticoid replacement. Dexamethasone alone would not be sufficient to manage the mineralocorticoid deficiency. Option: D. While saline infusion could temporarily help correct hypotension and hyponatremia, it does not address the underlying adrenal insufficiency. Saline alone cannot replace the necessary adrenal hormones (cortisol and aldosterone) that the patient is lacking, making it an incomplete treatment.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Adrenal Insufficiency:</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "01ed9b93",
      "audio": ""
    },
    {
      "text": "A young woman comes with complaints of weight loss, tachycardia, heat intolerance, and tremors. She has exophthalmos on examination. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Addison's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parkinson's disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Graves disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alzheimer's disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Graves disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Graves disease Graves' disease is an autoimmune disorder that leads to hyperthyroidism, and it commonly presents with symptoms such as weight loss, tachycardia, heat intolerance, tremors, and exophthalmos (bulging eyes), as described in the question.</p>\n<p><strong>Highyeild:</strong></p><p>Graves' disease is an autoimmune disorder that causes hyperthyroidism, characterized by the overproduction of thyroid hormones due to thyroid-stimulating immunoglobulins (TSI) that stimulate the thyroid gland. It is the most common cause of hyperthyroidism, typically presenting with symptoms such as weight loss, palpitations, increased appetite, heat intolerance, sweating, fatigue, and diarrhea. The physical examination often reveals a diffusely enlarged thyroid gland (goiter), tachycardia, tremors, and, in older patients, atrial fibrillation. A significant complication of Graves' disease is thyroid eye disease (TED), also known as Graves' ophthalmopathy, which affects approximately one-third of patients with the condition. TED is characterized by inflammation and swelling of the extraocular muscles and surrounding tissues, leading to symptoms like exophthalmos (protrusion of the eyes), diplopia (double vision), and visual impairment due to optic nerve compression in severe cases. The condition is often graded using the NO SPECS classification system, which assesses the severity based on symptoms and signs, ranging from no signs or symptoms to severe vision-threatening complications. The pathophysiology of TED involves an autoimmune process similar to that of Graves' disease, where TSI also targets the retro-orbital space, leading to inflammation and edema. The specific trigger for the development of TED is not fully understood but is thought to involve a combination of genetic predisposition and environmental factors, including smoking, which significantly increases the risk and severity of the disease.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Addison's disease typically causes symptoms like fatigue, weight loss, and hyperpigmentation, but not exophthalmos. Option: B. Parkinson's disease causes tremors, but it does not cause weight loss, heat intolerance, or exophthalmos. Option: D. Alzheimer's disease is a neurodegenerative disorder and does not present with hyperthyroid symptoms.</p>\n<p><strong>Extraedge:</strong></p><p>Signs of Graves' Ophthalmopathy:- Sign Description Exophthalmos Protrusion of the eyeballs due to swelling of retro-orbital tissues Dalrymple's Sign Lid retraction leading to a wide-eyed appearance; the upper eyelid is elevated Von Graefe's Sign Lid lag when the patient looks down; the upper eyelid lags behind the movement of the globe Kocher's Sign Inability to close the eyelids completely due to lid retraction; may result in corneal exposure Thyroid Bruits Audible bruits over the thyroid gland, indicating increased vascularity (less directly an eye sign) M\u00fcller's Sign Upper eyelid retraction seen when the patient is asked to look up</p>\n<p><strong>Table:</strong></p><p>#MANTRA Graves Disease algorithm:-</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aca47760",
      "audio": ""
    },
    {
      "text": "For MDR TB, what is the indication of short course bedaquiline?",
      "options": [
        {
          "label": "A",
          "text": "Resistance to rifampicin and sensitive 62.85% to fluoroquinolones",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mutation only to INH A and kat G gene",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rifampicin sensitive",
          "correct": false
        },
        {
          "label": "D",
          "text": "Extrapulmonary TB like tubercular meningitis",
          "correct": false
        }
      ],
      "correct_answer": "A. Resistance to rifampicin and sensitive 62.85% to fluoroquinolones",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Resistance to rifampicin and sensitive 62.85% to fluoroquinolones Bedaquiline is primarily used in MDR TB cases that involve rifampicin resistance, and it is particularly effective when the strain is sensitive to fluoroquinolones.</p>\n<p><strong>Highyeild:</strong></p><p>Multidrug-resistant tuberculosis (MDR TB) is a form of TB caused by Mycobacterium tuberculosis strains that are resistant to at least isoniazid (INH) and rifampicin, the two most powerful first-line anti-TB drugs. MDR TB can develop due to several factors, such as incomplete or improper TB treatment, poor adherence to drug regimens, incorrect drug prescribing, inadequate drug supply, or poor quality medications. This resistance makes standard TB treatment ineffective, necessitating the use of second-line drugs, which are less potent, more toxic, and often more expensive. MDR TB treatment is complex and prolonged, typically requiring 18-24 months of therapy, depending on the patient\u2019s resistance profile. The treatment regimen often includes second-line drugs like fluoroquinolones (e.g., levofloxacin, moxifloxacin) and injectable agents (e.g., amikacin, capreomycin). In recent years, newer drugs such as Bedaquiline and Delamanid have been introduced, offering hope for improved outcomes. Shorter MDR TB regimens, which include Bedaquiline, are now available for patients with fluoroquinolone-sensitive TB, reducing the treatment duration to around 9-12 months. The diagnosis of MDR TB is made through drug susceptibility testing (DST), which identifies resistance patterns. Rapid molecular tests, like GeneXpert, can quickly detect rifampicin resistance, serving as a proxy for MDR TB diagnosis. Patients with MDR TB often experience higher rates of treatment failure and relapse compared to drug-sensitive TB, and the mortality rate is significantly higher due to the challenges in effective treatment.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Mutations in the inhA and katG genes indicate isoniazid (INH) resistance, not rifampicin resistance. Bedaquiline is specifically recommended for MDR TB (which involves rifampicin resistance), not for cases where there\u2019s only isoniazid resistance. Option: C. Bedaquiline is typically reserved for MDR TB, which involves rifampicin resistance. If the TB strain is rifampicin-sensitive, standard first-line drugs are used, and there is no indication to use Bedaquiline. Option: D. Bedaquiline is not commonly indicated for extrapulmonary TB, especially not for tubercular meningitis , due to concerns about its penetration into the central nervous system and lack of evidence in these cases. Bedaquiline is mainly indicated for pulmonary MDR TB.</p>\n<p><strong>Table:</strong></p><p>#MANTRA TB drug resistance definitions :- Type of drug resistance Definition Mono/poly-drug-resistant Single or multi-drug resistance not meeting MDR/XDR criteria MDR b Concurrent rifampin and isoniazid resistance Pre-XDR MDR criteria plus fluoroquinolone resistance c XDR Pre-XDR criteria plus Bedaquiline or linezolid resistance</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2d85e79",
      "audio": ""
    },
    {
      "text": "An alcoholic patient presented to the emergency in an unconscious state. Relatives stated that he had a similar episode of binge drinking one week back. On examination, his glucose was 49 mg/dl. What is the appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "I/V thiamine followed by dextrose",
          "correct": true
        },
        {
          "label": "B",
          "text": "Injection vitamin K followed by dextrose infusion",
          "correct": false
        },
        {
          "label": "C",
          "text": "I/V 25% dextrose",
          "correct": false
        },
        {
          "label": "D",
          "text": "NS infusion",
          "correct": false
        }
      ],
      "correct_answer": "A. I/V thiamine followed by dextrose",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>I/V thiamine followed by dextrose In chronic alcoholics, administering dextrose before thiamine can precipitate Wernicke's encephalopathy due to a thiamine deficiency. Therefore, it is essential to give I/V thiamine first to prevent this complication, followed by dextrose to correct the hypoglycemia.</p>\n<p><strong>Highyeild:</strong></p><p>Management of chronic alcoholics involves addressing both the immediate and long-term medical, psychological, and social complications associated with alcohol dependence. Acute Management (Detoxification) Thiamine supplementation: Chronic alcoholics are at high risk for thiamine deficiency, which can lead to Wernicke\u2019s encephalopathy and Korsakoff syndrome. Administer IV thiamine (100 mg) before glucose to prevent precipitating these conditions. Electrolyte correction: Chronic alcohol use often leads to imbalances, particularly low magnesium, potassium, and phosphate. These should be corrected as needed. Manage withdrawal symptoms: Alcohol withdrawal can be life-threatening. Symptoms like tremors, seizures, hallucinations, and delirium tremens require prompt management: Benzodiazepines (e.g., diazepam or lorazepam) are the first-line treatment for alcohol withdrawal symptoms. Anticonvulsants or antipsychotics (e.g., haloperidol) may be needed in severe cases or for withdrawal-related seizures. Hydration and nutrition: Provide IV fluids, typically normal saline with added electrolytes. Address malnutrition with multivitamins and high-calorie nutritional support. Long-term Management (Rehabilitation and Prevention) Psychosocial interventions: Cognitive-behavioral therapy (CBT) and motivational interviewing are often used to address psychological dependence. Support groups like Alcoholics Anonymous (AA) can provide ongoing peer support and help maintain abstinence. Pharmacotherapy for alcohol dependence: Disulfiram: A deterrent therapy that causes unpleasant reactions (e.g., nausea, flushing) when alcohol is consumed. Naltrexone: Reduces alcohol craving by blocking opioid receptors. Acamprosate: Modulates neurotransmitter activity and reduces withdrawal symptoms, helping maintain abstinence. Liver disease management: Chronic alcohol abuse can lead to liver disease (e.g., alcoholic hepatitis, cirrhosis). Appropriate management of liver function and monitoring for complications like portal hypertension and hepatic encephalopathy are important. Treat comorbid conditions: Chronic alcoholics often have co-existing conditions like depression, anxiety, and other substance use disorders that require integrated management. Monitoring and Relapse Prevention Regular follow-ups to monitor liver function, mental health, and adherence to treatment. Encouraging abstinence through positive reinforcement and continuous participation in support programs.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Vitamin K is used for managing coagulopathies (e.g., in liver disease with impaired clotting), not hypoglycemia or thiamine deficiency. It has no role in the immediate management of hypoglycemia or prevention of Wernicke's encephalopathy in alcoholics. Option: C. Although dextrose corrects hypoglycemia, giving it before thiamine can precipitate Wernicke's encephalopathy in chronic alcoholics due to pre-existing thiamine deficiency. Hence, thiamine must be administered before Option: D. Normal saline (NS) may be useful for hydration but does not address the critical issues in this case: hypoglycemia and thiamine deficiency. It would neither raise the blood sugar nor prevent Wernicke\u2019s encephalopathy, making it inappropriate as the first intervention.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7d68c8f",
      "audio": ""
    },
    {
      "text": "A patient came to the emergency department with dyspnea and palpitations. He is a known case of chronic kidney disease. ECG of the patient is given below. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hyperkalemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hypokalemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypocalcemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypercalcemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Hyperkalemia",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183236890-QT86IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hyperkalemia The ECG finding of tall, tented T waves in a patient with chronic kidney disease suggests hyperkalemia . This condition occurs when the kidneys cannot effectively excrete potassium, leading to its buildup in the bloodstream, which can manifest as specific changes in the ECG.</p>\n<p><strong>Highyeild:</strong></p><p>Hyperkalemia is a medical condition characterized by elevated potassium levels in the blood, typically defined as a serum potassium concentration greater than 5.0 mEq/L. It can result from several factors, including decreased renal excretion due to chronic kidney disease, excessive potassium intake (e.g., from potassium-rich foods or supplements), tissue breakdown (as seen in hemolysis, rhabdomyolysis, trauma, or burns), and the use of certain medications like potassium-sparing diuretics, ACE inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Clinically, hyperkalemia may present with nonspecific symptoms such as muscle weakness, fatigue, palpitations, and dyspnea. Notably, it can lead to distinctive ECG changes: tall, tented T waves, a widening QRS complex, and, in severe cases, a sine-wave pattern or ventricular fibrillation, which can be life-threatening. Patients may also experience bradycardia and various arrhythmias. Management focuses on treating the underlying cause and may involve dietary modifications, administration of calcium gluconate to stabilize the cardiac membrane, insulin with glucose to facilitate potassium entry into cells, sodium bicarbonate (especially in cases of acidosis), and, in severe cases, dialysis to remove excess potassium. Regular monitoring of potassium levels and ECG changes is crucial in patients at risk for hyperkalemia.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Hypokalemia : This condition is characterized by low potassium levels, which typically present on an ECG as flattened T waves or U waves, not tall tented T waves. Option: C. Hypocalcemia : Low calcium levels can lead to a prolonged QT interval and changes in the ST segment but do not cause tall, tented T waves. Option: D. Hypercalcemia : Elevated calcium levels can also lead to a shortened QT interval and other changes but do not result in tall, tented T waves.</p>\n<p><strong>Table:</strong></p><p>#MANTRA ECG changes with Changing Potassium levels:- Hyperkalemia management:-</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e24c5b5",
      "audio": ""
    },
    {
      "text": "A patient presented with fatigue and tingling sensation in the arms, weight loss and history of polyuria. The following findings were detected on bone marrow biopsy. What is the probable cause?",
      "options": [
        {
          "label": "A",
          "text": "Subacute Combined Degeneration Due to Cobalamin Deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Multiple Myeloma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Subacute Degeneration Due to Diabetes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Megaloblastic Anemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Multiple Myeloma",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183236968-QT96IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Multiple Myeloma Increased plasma cells is a hallmark of multiple myeloma. It is the presence of abnormal clonal plasma cells, often exceeding 10% of the total marrow cellularity. The combination of fatigue, tingling sensation in the arms, weight loss, and a history of polyuria, along with bone marrow biopsy findings, suggests multiple myeloma.</p>\n<p><strong>Highyeild:</strong></p><p>Multiple myeloma (MM) is a plasma cell malignancy that causes overproduction of monoclonal immunoglobulins, leading to widespread organ damage. Clinically, it presents with bone pain, particularly in the back and ribs, due to lytic lesions and bone destruction. Fatigue is common due to normocytic normochromic anemia caused by marrow infiltration, and weight loss often reflects the chronic, malignant nature of the disease. Polyuria results from hypercalcemia , which is caused by bone resorption and can lead to dehydration and renal dysfunction. Patients often suffer from recurrent infections due to suppressed normal immunoglobulin production. On laboratory evaluation, MM is characterized by the presence of monoclonal (M) protein in serum or urine (detected via serum protein electrophoresis or urine protein electrophoresis), Bence-Jones proteins in urine, and elevated serum free light chains. Other findings include hypercalcemia, renal failure (increased creatinine), and elevated \u03b22-microglobulin (a marker of disease severity). Bone marrow biopsy reveals plasmacytosis, with plasma cells comprising more than 10% of the marrow. These plasma cells often have a \"clock-face\" appearance, eccentric nuclei, and cytoplasmic inclusions like Russell bodies . On blood smear, rouleaux formation (stacking of red blood cells) is seen due to high levels of circulating proteins. Imaging typically shows punched-out lytic lesions on X-rays, especially in the skull, spine, and long bones. Advanced imaging such as MRI or CT may reveal diffuse bone marrow involvement. Diagnosis is confirmed with bone marrow plasmacytosis, evidence of M protein, and the presence of end-organ damage (CRAB criteria: Calcium elevation, Renal failure, Anemia, Bone lesions). Treatment includes chemotherapy (e.g., bortezomib, lenalidomide), autologous stem cell transplant, and bisphosphonates to reduce bone damage. Despite treatment advances, MM remains incurable, with prognosis dependent on disease stage, genetic mutations, and response to therapy.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Subacute combined degeneration due to cobalamin deficiency : This condition is caused by vitamin B12 deficiency and presents with neurological symptoms like tingling (paresthesia), difficulty walking, and cognitive decline. Option: C. Subacute degeneration due to diabetes : Diabetes can cause neuropathy and polyuria, but it doesn\u2019t explain weight loss in this context or specific bone marrow findings like plasmacytosis. There is no direct association between diabetes and significant bone marrow pathology. Option: D. Megaloblastic anemia : Megaloblastic anemia, often due to folate or vitamin B12 deficiency, shows bone marrow findings of megaloblasts (large, immature red blood cells), hypersegmented neutrophils, and erythroid hyperplasia.</p>\n<p><strong>Extraedge:</strong></p><p>Electrophoresis:-</p>\n<p><strong>Table:</strong></p><p>#MANTRA Feature Multiple Myeloma (MM) Smouldering Multiple Myeloma (SMM) Monoclonal Gammopathy of Undetermined Significance (MGUS) M Protein High levels of M protein in serum/urine High levels of M protein, but lower than in MM Low levels of M protein (<3 g/dL) Plasma Cell Infiltration >10% clonal plasma cells in bone marrow >10% clonal plasma cells, but no end-organ damage <10% clonal plasma cells in bone marrow End-organ Damage (CRAB) Present (C: hypercalcemia, R: renal failure, A: anemia, B: bone lesions) Absent (No CRAB criteria) Absent Symptoms Symptomatic (bone pain, fatigue, weight loss, fractures, etc.) Asymptomatic, with risk of progression to MM Asymptomatic, very low risk of progression to MM Progression Risk Requires immediate treatment High risk of progression to MM (about 10% per year) Low risk of progression (1% per year) Bone Lesions Common (lytic bone lesions on imaging) Absent Absent Renal Dysfunction Common due to light chain nephropathy or hypercalcemia Absent Absent Treatment Immediate treatment (chemotherapy, stem cell transplant, etc.) No treatment, but close monitoring (watchful waiting) No treatment, regular follow-up with blood tests</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fec0422f",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient presents with dyspnea and chest pain. The pleural fluid analysis shows pleural protein/ serum protein > 0.5, and pleural LDH/ serum LDH > 0.4. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Congestive heart failure",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic kidney disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Liver cirrhosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tuberculosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Tuberculosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Tuberculosis The pleural fluid analysis shows a pleural protein/serum protein ratio > 0.5 and a pleural LDH/serum LDH ratio > 0.4, which are criteria for an exudative pleural effusion based on Light's criteria. Among the given options, the most likely cause of an exudative effusion is tuberculosis.</p>\n<p><strong>Highyeild:</strong></p><p>Light's criteria are used to differentiate between exudative and transudative pleural effusions, which is crucial for determining the underlying cause of the effusion. According to these criteria, a pleural effusion is classified as exudative if at least one of the following three conditions is met: Pleural Protein/Serum Protein Ratio: This ratio exceeds 0.5, indicating a higher concentration of protein in the pleural fluid compared to the serum. This suggests increased permeability of pleural membranes often seen in inflammatory or malignant conditions. Pleural LDH/Serum LDH Ratio : This ratio exceeds 0.4, signifying elevated lactate dehydrogenase (LDH) levels in the pleural fluid. LDH is an enzyme released during tissue damage, and its increased levels in the pleural space often indicate cellular destruction or inflammation. Pleural LDH Level: The absolute level of pleural LDH is greater than 200 IU/L. Elevated LDH levels reflect the presence of inflammatory cells, which are common in exudative effusions due to infections, malignancies, or autoimmune diseases. If none of these criteria are met, the effusion is typically classified as transudative , commonly resulting from systemic conditions like congestive heart failure, cirrhosis, or nephrotic syndrome. Pleural fluid PF/serum protein ratio PF/serum LD ratio PF LD (U/L) Transudative < 0.5 < 0.6 < 2/3 URL Exudative* \u2265 0.5 \u2265 0.6 \u2265 2/3 URL *Effusions are identified as exudative if one or more conditions are met. LD - lactate dehydrogenase; PF \u2013 pleural fluid; URL \u2013 upper - reference limit of serum LD.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. CHF typically leads to transudative pleural effusions , characterized by low levels of protein and LDH in the pleural fluid. The protein/serum protein ratio is usually less than 0.5, and the LDH/serum LDH ratio is generally less than 0.4. Option: B. CKD usually results in transudative effusions due to fluid overload and reduced oncotic pressure. The pleural fluid in CKD typically shows low protein and LDH levels, failing to meet the exudative criteria. Option: C. Liver cirrhosis commonly causes transudative pleural effusions due to portal hypertension and low serum albumin levels. The characteristics of pleural fluid in cirrhosis do not meet the exudative criteria outlined by Light's criteria.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "69926d60",
      "audio": ""
    },
    {
      "text": "An adolescent presented with fever, purpura on the thigh, swelling of the right knee and left ankle, and abnormal and diastolic murmur in the cardiac apical area. He was seronegative for rheumatoid factor. What is the probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute rheumatic fever",
          "correct": true
        },
        {
          "label": "B",
          "text": "Juvenile idiopathic arthritis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Seronegative arthropathy",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute rheumatic fever",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Acute rheumatic fever Acute Rheumatic Fever (ARF) often follows a streptococcal throat infection. The symptoms include fever, arthritis (as seen with swelling of the knees and ankles), and a characteristic skin rash (purpura may indicate vasculitis). The presence of a diastolic murmur suggests possible valvular involvement, typically affecting the mitral valve, leading to mitral regurgitation.</p>\n<p><strong>Highyeild:</strong></p><p>Acute rheumatic fever (ARF) is an inflammatory disease that can arise after an infection with group A Streptococcus, particularly following streptococcal pharyngitis or tonsillitis. It predominantly affects children and adolescents and can lead to serious complications if not treated promptly. The clinical manifestations of ARF are categorized according to the Jones criteria, which include: Carditis: Inflammation of the heart, which can lead to: Murmurs: Often a diastolic murmur due to mitral regurgitation or an aortic regurgitation murmur. Cardiomegaly: Enlarged heart on imaging. Heart Failure: In severe cases, presenting with signs of heart failure due to valve dysfunction. Arthritis: Typically presents as: Migratory Polyarthritis: Involves large joints such as the knees, ankles, elbows, and wrists. Joints often become swollen, red, and painful, with symptoms resolving in one joint as they begin in another. Erythema Marginatum: A characteristic rash that is: Non-pruritic: Pink or red in color with a clear center and distinct edges, often appearing on the trunk and proximal extremities. Subcutaneous Nodules: Small, painless nodules located over bony prominences or near joints, indicating chronic inflammation. Sydenham Chorea: A neurological manifestation characterized by rapid, involuntary movements, especially of the face and limbs, often occurring weeks to months after the initial infection. Fever: Generally low-grade but may be accompanied by malaise and fatigue. The diagnosis of ARF relies on the presence of a preceding streptococcal infection, typically confirmed by positive throat culture or rapid antigen detection test, in addition to fulfilling the Jones criteria. The management includes the use of anti-inflammatory agents like aspirin or corticosteroids to control inflammation and pain, along with long-term antibiotic prophylaxis (usually penicillin) to prevent recurrences and subsequent rheumatic heart disease. Early intervention is critical to reduce the risk of long-term cardiac complications and improve patient outcomes.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Juvenile Idiopathic Arthritis : While this could explain the joint swelling, it is not typically associated with fever and purpura or cardiac murmurs. Option: C. Rheumatoid Arthritis : This is less likely in an adolescent, particularly in the absence of rheumatoid factor and the acute presentation of symptoms. Option: D. Seronegative Arthropathy : This is a broad term that generally includes a group of inflammatory joint diseases but does not specifically account for the fever and cardiac findings.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Prophylaxis for Streptococcal throat Infection:- \u25cf       ARF only \u25cf       For 10 years after last ARF or until age 21 years (whichever is longer) \u25cf       Moderate RHD \u25cf       For 10 years after last ARF or until age 35 years (whichever is longer) \u25cf       Severe RHD \u25cf       Until age 40 or longer \u25cf       After heart valve surgery \u25cf       Until age 40 or longer</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fcf6acbf",
      "audio": ""
    },
    {
      "text": "A female presents with choreo-athetoid movements, dysarthria, and dystonia with the given finding. Which of the following is the best investigation to confirm the same?",
      "options": [
        {
          "label": "A",
          "text": "Serum ceruloplasmin levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatic copper content",
          "correct": true
        },
        {
          "label": "C",
          "text": "24-hour urinary excretion of copper",
          "correct": false
        },
        {
          "label": "D",
          "text": "Blood copper levels",
          "correct": false
        }
      ],
      "correct_answer": "B. Hepatic copper content",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183237033-QT105IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hepatic copper content In this scenario, where a female patient presents with choreo-athetoid movements, dysarthria, dystonia, and the presence of a Kayser-Fleischer (KF) ring, the diagnosis is Wilson's disease. Hepatic copper content is the most sensitive and accurate test for diagnosing Wilson's disease. It directly measures the accumulation of copper in the liver, which is the primary defect in this condition.</p>\n<p><strong>Highyeild:</strong></p><p>Wilson's disease is an inherited disorder that results in excessive accumulation of copper in the body, primarily affecting the liver, brain, and other tissues. It is caused by a mutation in the ATP7B gene, which is responsible for the transport of copper into bile and the incorporation of copper into ceruloplasmin, the main copper-carrying protein in the blood. The condition is autosomal recessive, meaning that both copies of the gene must be mutated for the disease to manifest. Clinical Presentation: Liver Symptoms: Often presents with liver dysfunction, which may include hepatomegaly, jaundice, and cirrhosis. Acute liver failure can occur, particularly in adolescents. Neurological Symptoms: Patients may exhibit a range of neurological manifestations such as: Choreoathetosis: Involuntary, irregular movements. Dystonia: Sustained muscle contractions causing twisting movements. Dysarthria: Difficulty in speech due to muscle control problems. Parkinsonism: Tremors, rigidity, and bradykinesia may develop. Psychiatric Symptoms: Mood disturbances, personality changes, and cognitive decline are common, leading to psychiatric manifestations. Diagnosis: Kayser-Fleischer Rings: Greenish or golden-brown rings around the cornea due to copper deposition. These can be seen on slit-lamp examination. Serum Ceruloplasmin: Typically low in Wilson\u2019s disease. 24-hour Urinary Copper Excretion: Elevated levels (>100 \u00b5g/24 hours) indicate excessive copper excretion, confirming the diagnosis. Liver Biopsy: May be performed to measure hepatic copper content if other tests are inconclusive; copper levels >250 \u00b5g/g dry weight of liver tissue are indicative of Wilson's disease. Management: Chelating Agents: Medications such as penicillamine and trientine are used to promote the excretion of copper from the body. Zinc Therapy: Zinc salts can be used to block the intestinal absorption of copper and are often employed for maintenance therapy after initial chelation. Liver Transplantation: Considered for patients with severe liver disease or acute liver failure.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Serum ceruloplasmin levels are often decreased in Wilson's disease, but they can also be low in other conditions. They are not as specific or sensitive as hepatic copper content. Option: C. 24-hour urinary excretion of copper is a useful screening test, but it can be normal or elevated in some cases of Wilson's disease, especially in the early stages. Option: D. Blood copper levels can be low, normal, or elevated depending on the stage of the disease and are therefore not a reliable diagnostic test.</p>\n<p><strong>Extraedge:</strong></p><p>There is often confusion between Fleischer rings and Kayser-Fleischer rings . Kayser-Fleischer rings are indicative of Wilson's disease, resulting from copper deposits in the Descemet membrane of the cornea. In contrast, Fleischer rings are caused by iron deposits in the basal epithelial cells and are commonly associated with keratoconus. Fleischer ring- Kayser-Fleischer ring-</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9ac24e60",
      "audio": ""
    },
    {
      "text": "A 27-year-old footballer collapsed on the field and could not be revived. An autopsy was conducted and on cardiac biopsy, the left ventricle was hypertrophied. Identify the possible cause for the same:",
      "options": [
        {
          "label": "A",
          "text": "Ischemic cardiomyopathy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arrhythmogenic right ventricular dysplasia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypertrophic cardiomyopathy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Takotsubo cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypertrophic cardiomyopathy",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732183237076-QT109IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy (HCM) is a genetic condition characterized by asymmetric left ventricular hypertrophy, often without any obvious cause like hypertension or valvular disease. It is commonly seen in young athletes and can lead to sudden cardiac arrest, especially during intense physical activity.</p>\n<p><strong>Highyeild:</strong></p><p>Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening (hypertrophy) of the heart muscle, particularly the left ventricle. It is one of the most common inherited cardiac diseases and a leading cause of sudden cardiac death in young athletes. Genetics : HCM is usually inherited in an autosomal dominant manner. Mutations in genes encoding sarcomeric proteins (such as MYH7, MYBPC3, and TNNT2) are commonly involved. Family history is significant; individuals with a family member diagnosed with HCM have a higher risk. Pathophysiology : The primary feature is asymmetrical hypertrophy of the left ventricle, which can obstruct blood flow out of the heart during systole (systolic anterior motion of the mitral valve). This can lead to increased diastolic pressure, causing heart failure symptoms and increased risk of arrhythmias. Clinical Presentation: Symptoms may include: Dyspnea (shortness of breath), especially with exertion. Chest pain during physical activity. Palpitations or irregular heartbeats. Syncope (fainting) or near-syncope, particularly during exercise. Many individuals may be asymptomatic and diagnosed incidentally through imaging. Diagnosis: Echocardiogram: Key tool for diagnosis, showing left ventricular hypertrophy (typically >15 mm) and possible left ventricular outflow tract obstruction. Electrocardiogram (ECG): May reveal signs of left ventricular hypertrophy, abnormal repolarization, and arrhythmias. Genetic testing: Can confirm the diagnosis in individuals with a family history. Cardiac MRI: Useful for assessing the extent of hypertrophy and differentiating HCM from other conditions. Complications: Sudden Cardiac Death: Particularly in young athletes, often due to arrhythmias. Heart Failure: Due to diastolic dysfunction or outflow tract obstruction. Atrial Fibrillation: Can occur due to left atrial enlargement and may increase the risk of stroke. Management : Lifestyle Modifications: Avoiding extreme exertion and competitive sports. Medications: Beta-blockers: Help reduce heart rate and improve symptoms. Calcium channel blockers: May be used for relief of symptoms. Disopyramide: Can be beneficial in patients with obstruction.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Ischemic cardiomyopathy : This is primarily due to coronary artery disease and typically occurs in older individuals, not commonly in a young athlete. It usually presents with heart failure and may show dilated heart chambers rather than isolated hypertrophy. Option: B. Arrhythmogenic right ventricular dysplasia : This condition primarily affects the right ventricle and is characterized by fibro-fatty replacement of myocardial tissue, leading to arrhythmias. It is not typically associated with left ventricular hypertrophy. Option: D. Takotsubo cardiomyopathy : Also known as stress-induced cardiomyopathy, this condition often presents with transient left ventricular dysfunction and apical ballooning, typically following extreme stress. It does not lead to hypertrophy.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2b85798e",
      "audio": ""
    },
    {
      "text": "A patient presents with pigmentation of knuckles, oral mucosa, palm and hands, and tachycardia. The blood pressure of the patient is 80/60 mmHg and Na+ 130mmHg. What is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Conn's syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary adrenal insufficiency",
          "correct": true
        },
        {
          "label": "C",
          "text": "Vitamin B12 deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cushing syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Primary adrenal insufficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Primary adrenal insufficiency The most probable diagnosis is Primary Adrenal Insufficiency (Addison's disease). The patient's symptoms of pigmentation in the knuckles, oral mucosa, and palms indicate increased melanin production due to elevated adrenocorticotropic hormone (ACTH) levels, which occurs when cortisol is low. Additionally, the hypotension (80/60 mm Hg) and hyponatremia (Na+ 130 mEq/L) suggest a lack of aldosterone, leading to sodium loss and volume depletion.</p>\n<p><strong>Highyeild:</strong></p><p>Adrenal insufficiency is a condition characterized by inadequate production of hormones from the adrenal glands, leading to various physiological disturbances. It can be classified into three main types: primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency, and tertiary adrenal insufficiency. Primary adrenal insufficiency results from autoimmune destruction of the adrenal cortex, although it can also be caused by infections (e.g., tuberculosis), adrenal hemorrhage, or metastatic cancer. In this type, both cortisol and aldosterone production are deficient, affecting glucose metabolism, electrolyte balance, and the body's ability to respond to stress. Secondary adrenal insufficiency occurs due to inadequate production of adrenocorticotropic hormone (ACTH) by the pituitary gland, often resulting from pituitary tumors or prolonged use of glucocorticoids that suppress ACTH secretion. In this case, cortisol levels are primarily affected, while aldosterone production may remain normal due to regulation by the renin-angiotensin system. Tertiary adrenal insufficiency results from a lack of corticotropin-releasing hormone (CRH) from the hypothalamus, usually due to prolonged glucocorticoid therapy, and presents similarly to secondary adrenal insufficiency. Common symptoms of adrenal insufficiency include fatigue, weakness, weight loss, decreased appetite, hyperpigmentation of the skin (especially in primary adrenal insufficiency), hypotension, hyperkalemia, hyponatremia, nausea, vomiting, abdominal pain, and mood changes. In severe cases, patients may experience an adrenal crisis, a life-threatening condition characterized by severe hypotension, shock, and altered mental status.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Conn's Syndrome : This condition (primary hyperaldosteronism) typically presents with hypertension, hypokalemia, and metabolic alkalosis. The low blood pressure and low sodium level do not support this diagnosis. Option: C. Vitamin B12 Deficiency : This condition primarily presents with symptoms related to anemia and neurological deficits, such as weakness, fatigue, glossitis, and peripheral neuropathy. It does not typically cause hyperpigmentation or low blood pressure. Option: D. Cushing Syndrome : This condition is characterized by excess cortisol, which leads to features like hypertension, weight gain, and skin changes (but not usually hyperpigmentation of the areas mentioned). The low blood pressure and signs of dehydration are not consistent with Cushing syndrome.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Adrenal Insufficiency:-</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "877ceb84",
      "audio": ""
    },
    {
      "text": "An elderly patient who is a known case of scleroderma presented with shortness of breath. On examination, her right ventricular pressure was 70-80 mmHg and later on catheterization, pulmonary capillary wedge pressure was found to be 35 mmHg. Which of the following is true regarding her condition?",
      "options": [
        {
          "label": "A",
          "text": "Calcium channel blockers given for all the patients",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lung transplant is the best treatment, if identified early",
          "correct": false
        },
        {
          "label": "C",
          "text": "Endothelin receptor antagonists improves symptoms",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lifestyle modification is the only possible approach",
          "correct": false
        }
      ],
      "correct_answer": "C. Endothelin receptor antagonists improves symptoms",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Endothelin receptor antagonists improves symptoms The patient's elevated right ventricular pressure and pulmonary capillary wedge pressure suggest pulmonary arterial hypertension (PAH) related to scleroderma. Among the options, endothelin receptor antagonists, such as bosentan, improve symptoms and are effective in managing PAH.</p>\n<p><strong>Highyeild:</strong></p><p>Pulmonary arterial hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to right ventricular failure. It is defined by a mean pulmonary artery pressure (mPAP) of \u226520 mmHg at rest, with a pulmonary vascular resistance (PVR) >3 Wood units, and normal pulmonary capillary wedge pressure (PCWP) \u226415 mmHg, which excludes left heart disease. Pathophysiology: PAH involves endothelial dysfunction in the pulmonary arteries, leading to vasoconstriction, vascular remodeling, and increased pulmonary vascular resistance. Over time, this results in right ventricular hypertrophy and eventually right heart failure due to the increased workload. Causes: PAH can be idiopathic, heritable, or associated with conditions like connective tissue diseases (e.g., scleroderma), congenital heart defects, HIV infection, portal hypertension, and drugs/toxins (e.g., appetite suppressants). Symptoms: Common symptoms include dyspnea on exertion, fatigue, chest pain, syncope, and peripheral edema. These symptoms are often nonspecific, leading to delayed diagnosis. Diagnosis: Diagnosis is confirmed through right heart catheterization, which measures pulmonary pressures and vascular resistance. Other tests include echocardiography, ECG, CT, and ventilation-perfusion (V/Q) scans to assess the heart and lung function and rule out other causes. Management: Pharmacological treatments include: Endothelin receptor antagonists (e.g., bosentan) to reduce vasoconstriction. Phosphodiesterase-5 inhibitors (e.g., sildenafil) to promote vasodilation. Prostacyclin analogs (e.g., epoprostenol) to enhance vasodilation and inhibit smooth muscle cell proliferation. Calcium channel blockers for the small subset of patients who respond to vasoreactivity testing. Lung transplantation is considered for advanced cases that do not respond to medical therapy.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Calcium channel blockers are only effective in a small subset of patients with PAH who demonstrate a positive vasoreactivity test, so they are not given to all patients. Option: B. Lung transplant may be a treatment for advanced PAH, but it is not the best treatment if identified early. Medical therapies like endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs are preferred early on. Option: D. Lifestyle modification alone is insufficient as PAH requires medical management.</p>\n<p><strong>Extraedge:</strong></p><p>Disease Antibodies SLE dsDNA & Anti-Smith Ab Drug Induced SLE Anti-Histone Ab Subacute Cutaneous SLE SSA (RO) Ab Scleroderma Anti-Scl 70 CREST Anti-Centromere Ab MCTD RNP Ab Poly/Dermatomyositis Anti-Jo or Mi-2 Ab Sjogren's Syndrome SSA (RO)/SSB(La) Ab Wegener's C-ANCA Microscopic Polyarteritis Angiitis P-ANCA</p>\n<p><strong>Table:</strong></p><p>#MANTRA Diffuse Vs Limited Scleroderma:- Diffuse Limited \u25cf       Lung fibrosis (severe in 15%) \u25cf       Lung fibrosis (severe in 15%) \u25cf       Heart (severe in 10%) \u25cf       Minimal heart \u25cf       Kidney (severe in 15-20%) \u25cf       Minimal kidney \u25cf       Large joint contractures \u25cf       Late: Pulmonary hypertension (~15%) \u25cf       Disability, fatigue, MSK pains \u25cf       Late: Primary biliary cirrhosis (6-8%)</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "355e250a",
      "audio": ""
    },
    {
      "text": "A 50-year-old female presented with dyspnea and angina episodes. On workup, she is found to have aortic stenosis. Which of the following findings favor the diagnosis of aortic stenosis over aortic regurgitation?",
      "options": [
        {
          "label": "A",
          "text": "Increase in preload causes more reduction in myocardial oxygen demand than increase in afterload",
          "correct": false
        },
        {
          "label": "B",
          "text": "Workload has nothing to do with myocardial 02 consumption",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aortic stenosis causes reduced pressure than aortic valve",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase in myocardial O2 consumption is seen with increased pressure work than volume",
          "correct": true
        }
      ],
      "correct_answer": "D. Increase in myocardial O2 consumption is seen with increased pressure work than volume",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Increase in myocardial O2 consumption is seen with increased pressure work than volume In aortic stenosis, the left ventricle faces increased pressure overload due to the narrowed aortic valve, which requires more force to eject blood. This pressure work significantly increases myocardial oxygen consumption. In contrast, aortic regurgitation leads to volume overload, which has a different hemodynamic effect. Thus, increased oxygen consumption due to pressure work is a key finding favoring aortic stenosis over aortic regurgitation.</p>\n<p><strong>Highyeild:</strong></p><p>Aortic stenosis (AS) is a condition characterized by the narrowing of the aortic valve, which restricts blood flow from the left ventricle into the aorta and onward to the rest of the body. It leads to increased pressure within the left ventricle as it struggles to pump blood through the narrowed valve. This results in progressive left ventricular hypertrophy, and eventually, heart failure if untreated. Causes: Age-related calcification: The most common cause, particularly in older adults, due to calcium deposits on the valve leaflets. Congenital bicuspid aortic valve: A congenital defect where the aortic valve has two leaflets instead of the usual three, which is more prone to degeneration. Rheumatic fever: In developing countries, rheumatic heart disease can lead to valve scarring and eventual stenosis. Pathophysiology: In AS, the aortic valve orifice narrows, increasing afterload on the left ventricle. To maintain cardiac output, the left ventricle compensates by developing concentric hypertrophy (thickening of the ventricular wall). Over time, this leads to diastolic dysfunction and increased myocardial oxygen demand, causing symptoms like angina and eventually heart failure. Symptoms: Dyspnea on exertion: Due to heart failure as the left ventricle cannot meet the body's demands. Angina: Occurs due to increased myocardial oxygen demand from left ventricular hypertrophy. Syncope: Typically exertional, due to the fixed cardiac output unable to meet increased demands. Heart failure symptoms: In advanced cases, with fatigue, peripheral edema, and pulmonary congestion. Examination Findings: Ejection systolic murmur: Best heard at the right second intercostal space, radiating to the carotids. The murmur becomes louder and peaks later as stenosis worsens. Pulsus parvus et tardus: Weak and delayed carotid pulse due to the obstruction. Narrow pulse pressure: Due to reduced stroke volume. Diagnosis: Echocardiography: The main diagnostic tool to assess valve anatomy, stenosis severity (valve area and gradients), and left ventricular function. Doppler ultrasound: Measures the pressure gradient across the valve. Cardiac catheterization: Used if non-invasive tests are inconclusive. Treatment: Medical management: Symptomatic relief with diuretics and medications for heart failure, though these do not address the underlying stenosis. Surgical intervention: Aortic valve replacement (AVR): The definitive treatment for severe AS. It can be either surgical AVR or transcatheter aortic valve implantation (TAVI) for patients with high surgical risk. Balloon valvuloplasty: Temporarily relieves stenosis, often used in critically ill patients not eligible for surgery.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Increase in preload causes more reduction in myocardial oxygen demand than increase in afterload : This is incorrect because afterload (pressure the heart must work against to eject blood) is the primary issue in aortic stenosis , not preload. Increased afterload, as seen in aortic stenosis, leads to higher myocardial oxygen demand. Option: B. Workload has nothing to do with myocardial O2 consumption : This is incorrect because the heart\u2019s workload (both pressure and volume work) is directly related to myocardial oxygen consumption . Increased pressure or volume demands increase oxygen requirements. Option: C. Aortic stenosis causes reduced pressure than aortic valve : This is incorrect. In aortic stenosis, the left ventricular pressure increases significantly as it works against the narrowed valve, leading to elevated pressure upstream (in the ventricle) rather than reduced pressure.</p>\n<p><strong>Extraedge:</strong></p><p>Murmurs of aortic Stenosis:</p>\n<p><strong>Table:</strong></p><p>#MANTRA Feature Aortic Stenosis (AS) Aortic Regurgitation (AR) Mitral Stenosis (MS) Mitral Regurgitation (MR) Valve affected Aortic valve Aortic valve Mitral valve Mitral valve Pathophysiology Narrowing of aortic valve, increased afterload Incompetent aortic valve, blood flows back into LV during diastole Narrowing of mitral valve, impeding flow from LA to LV Incompetent mitral valve, blood flows back into LA during systole Main cause Age-related calcification, congenital bicuspid valve, rheumatic fever Aortic root dilation, bicuspid aortic valve, rheumatic fever Rheumatic fever, congenital heart disease Mitral valve prolapse, rheumatic fever, ischemic heart disease Murmur Ejection systolic murmur, loudest at right second intercostal space, radiates to carotids Early diastolic murmur, decrescendo, best heard at left sternal border Diastolic rumble, best heard at the apex, accentuated with exercise Holosystolic (pansystolic) murmur, best heard at the apex, radiates to the axilla Pulse Pulsus parvus et tardus (weak, delayed carotid pulse) Bounding pulse (due to wide pulse pressure) Low-volume pulse Normal or low-volume pulse, brisk carotid upstroke Heart sound changes Soft or absent S2, possible S4 Soft S1, possible S3 Loud S1, opening snap Soft S1, possible S3 Complications Left ventricular hypertrophy, heart failure, syncope Left ventricular dilation, heart failure, angina Pulmonary hypertension, atrial fibrillation, right heart failure Left atrial dilation, atrial fibrillation, pulmonary hypertension Pulse pressure Narrow pulse pressure Wide pulse pressure Normal or low pulse pressure Normal or slightly increased pulse pressure Symptoms Angina, syncope, dyspnea on exertion Dyspnea, fatigue, angina, wide pulse pressure Dyspnea on exertion, fatigue, hemoptysis, palpitations Dyspnea, fatigue, orthopnea, palpitations</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37176ea9",
      "audio": ""
    },
    {
      "text": "In a patient with type 1 diabetes with 3rd stage beta cell damage, which of the following situations is associated with the same?",
      "options": [
        {
          "label": "A",
          "text": "Autoimmune positive with dysglycemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Autoimmune positive with normoglycemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Autoimmune negative with normoglycemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Autoimmune negative with dysglycemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Autoimmune positive with dysglycemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Autoimmune positive with dysglycemia In type 1 diabetes, stage 3 is characterized by significant beta-cell damage, resulting in dysglycemia (abnormal blood glucose levels), which often presents as hyperglycemia or clinical diabetes. Patients at this stage typically have positive autoimmune markers, indicating the autoimmune destruction of pancreatic beta cells.</p>\n<p><strong>Highyeild:</strong></p><p>Type 1 diabetes (T1D) is a chronic autoimmune disease in which the immune system mistakenly targets and destroys the insulin-producing beta cells in the pancreas, leading to an absolute insulin deficiency. This condition accounts for about 5-10% of all diabetes cases and typically develops in childhood, adolescence, or early adulthood, though it can occur at any age. The exact cause is multifactorial, involving genetic predisposition (e.g., HLA-DR and HLA-DQ genes) and environmental triggers, such as viral infections or toxins, which may initiate the autoimmune process. As beta cells are destroyed, the pancreas produces less insulin, a hormone necessary for glucose uptake into cells for energy. This leads to elevated blood glucose levels (hyperglycemia). The hallmark symptoms of T1D are polyuria (excessive urination), polydipsia (excessive thirst), polyphagia (increased hunger), unexplained weight loss, and fatigue. If untreated, this can progress to diabetic ketoacidosis (DKA) , a life-threatening condition caused by the accumulation of ketones due to fat metabolism in the absence of insulin. T1D is characterized by the presence of autoimmune markers such as antibodies against insulin (IAA), glutamic acid decarboxylase (GAD65), islet cell antigens (ICA), and tyrosine phosphatases (IA-2). These antibodies may appear years before the onset of clinical symptoms, with disease progression categorized into stages: stage 1 (autoimmunity with normoglycemia), stage 2 (autoimmunity with dysglycemia), and stage 3 (clinical diabetes).</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Autoimmune positive with normoglycemia reflects earlier stages of type 1 diabetes (stage 1), where autoimmunity is present, but glucose levels remain normal. Option: C. Autoimmune negative with normoglycemia suggests no autoimmunity and normal glucose metabolism, which is unrelated to type 1 diabetes. Option: D. Autoimmune negative with dysglycemia points to other forms of diabetes or glucose intolerance, not autoimmune type 1 diabetes.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Diabetes type 1 vs type 2:- Feature Type 1 Diabetes Type 2 Diabetes Incidence 8% of diabetes diagnoses >90% of diabetes diagnoses Pathology Insulin deficiency due to autoimmune destruction of beta cells Cells become resistant to insulin; Inadequate insulin secretion by the pancreas Risk Factors Family history, other autoimmune diseases (celiac, hypothyroidism, etc.) Family history, high BMI, low physical activity, ethnicity - South Asian, African, Caribbean Onset Sudden onset in younger patients Gradual onset in older patients Symptoms Polyuria, polydipsia, polyphagia, fatigue, unexpected weight loss, blurred vision Gradual onset in older patients Treatment Insulin Lifestyle changes, oral hypoglycemics, insulin Ketoacidosis Common complication Rare Complication Endogenous Insulin Absent or very low Low, normal, or high Endogenous Insulin Cannot be prevented Can be prevented through lifestyle changes Reversibility Cannot be reversed Can be reversed with early diagnosis and lifestyle changes</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4b370c9",
      "audio": ""
    },
    {
      "text": "A 26-year-old patient with bronchial asthma who has two episodes in the daytime and one episode at night time per week is prescribed albuterol to use as and when required. MDI FEV1 improved from 76% to 83% after taking bronchodilator. What is the further treatment plan? MDI: metered dose inhaler FEV1: forced expiratory volume in 1 second",
      "options": [
        {
          "label": "A",
          "text": "Add oral prednisolone 10 mg daily",
          "correct": false
        },
        {
          "label": "B",
          "text": "Continue albuterol whenever required",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add fluticasone propionate 40 mg BD",
          "correct": true
        },
        {
          "label": "D",
          "text": "Change to salbutamol MDI twice daily",
          "correct": false
        }
      ],
      "correct_answer": "C. Add fluticasone propionate 40 mg BD",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Add fluticasone propionate 40 mg BD The patient has mild persistent asthma, characterized by symptoms occurring more than twice a week but not daily and nighttime symptoms occurring about once a week. The FEV1 of 76-83% after bronchodilator use suggests that there is still room for improvement in lung function and control of symptoms. Inhaled corticosteroids (like fluticasone) are the preferred next step in treatment for mild persistent asthma, as they reduce inflammation and improve long-term control.</p>\n<p><strong>Highyeild:</strong></p><p>Asthma is a chronic inflammatory disease of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning. These symptoms are associated with variable airflow obstruction, which is often reversible either spontaneously or with treatment. Asthma is driven by airway hyperresponsiveness, where triggers like allergens, cold air, exercise, or respiratory infections cause bronchoconstriction and inflammation. The underlying pathophysiology involves inflammation of the bronchial walls, excessive mucus production, and tightening of airway muscles. This results in airflow limitation, which can be measured by spirometry, showing reduced FEV1 and a significant improvement after bronchodilator use. The management of asthma includes short-acting beta-agonists (SABAs) like albuterol for immediate relief and inhaled corticosteroids (ICS) for long-term control to reduce airway inflammation. In more severe cases, additional medications such as long-acting beta-agonists (LABAs) or oral corticosteroids may be required. Asthma severity and control are regularly monitored to adjust treatment and prevent exacerbations. Proper education on trigger avoidance, medication adherence, and inhaler techniques is essential for effective asthma management. GINA 2021 guidelines</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Add oral prednisolone 10 mg daily is inappropriate for mild asthma; oral steroids are reserved for more severe cases or acute exacerbations. Option: B. Continue albuterol whenever required is incorrect because the patient needs better control beyond just a rescue inhaler. Option: D. Change to salbutamol MDI twice daily is incorrect because salbutamol is a short-acting bronchodilator, not a long-term controller.</p>\n<p><strong>Extraedge:</strong></p><p>Tezepelumab is a novel monoclonal antibody currently in development for asthma treatment that targets thymic stromal lymphopoietin (TSLP). TSLP is a key initiator of airway inflammation and hyperresponsiveness. Designed for patients with moderate to severe asthma, regardless of eosinophilic phenotype, Tezepelumab has shown significant reductions in asthma exacerbations and improvements in lung function in clinical trials. Administered via subcutaneous injection, its approval could offer a new, effective option for patients with uncontrolled asthma.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Management of Acute Asthma:-</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f05028fa",
      "audio": ""
    },
    {
      "text": "A woman presented with an irregularly irregular rhythm with a heart rate of 150 bpm. On auscultation P2 was loud and no murmur was heard. What would be the JVP finding?",
      "options": [
        {
          "label": "A",
          "text": "Rapid x descent",
          "correct": false
        },
        {
          "label": "B",
          "text": "Absent a wave",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cannon a wave",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rapid y descent",
          "correct": false
        }
      ],
      "correct_answer": "B. Absent a wave",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Absent a wave In atrial fibrillation, the atrial contraction is ineffective, leading to an absent \"a\" wave in the JVP waveform, as there is no coordinated atrial contraction due to the irregular rhythm.</p>\n<p><strong>Highyeild:</strong></p><p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, characterized by rapid and irregular electrical activity in the atria, leading to ineffective atrial contraction. This condition results in an irregularly irregular ventricular response, which can vary widely in rate. AF is classified into several types: paroxysmal (intermittent episodes), persistent (lasting more than a week), long-standing persistent, and permanent (AF that is sustained despite attempts to restore normal rhythm). The pathophysiology of AF involves a combination of electrical and structural remodeling of the atria. Triggering factors can include atrial dilation, hypertension, heart failure, valvular disease, and underlying coronary artery disease. The chaotic electrical impulses in the atria disrupt normal conduction pathways, leading to ineffective atrial contraction and potential thrombus formation due to stagnant blood flow, particularly in the left atrial appendage. Clinical Presentation- Patients with AF may experience a range of symptoms, including palpitations, fatigue, shortness of breath, and dizziness. However, some individuals may be asymptomatic. The irregularly irregular pulse is a hallmark sign, often detected during a routine examination. AF can also increase the risk of stroke and other thromboembolic events, making early detection and management crucial. Diagnosis is typically made through an electrocardiogram (ECG), which reveals an absence of distinct P waves and an irregularly irregular rhythm with varying R-R intervals. Additional investigations, such as echocardiography, may be performed to assess underlying structural heart disease and to evaluate left atrial size. Management strategies for AF focus on rate control, rhythm control, and stroke prevention. Rate control can be achieved with medications such as beta-blockers, calcium channel blockers, or digoxin to manage the ventricular rate. Rhythm control may involve antiarrhythmic medications or procedures such as electrical cardioversion or catheter ablation to restore normal sinus rhythm. Anticoagulation therapy is critical to reduce the risk of stroke, guided by risk stratification tools such as the CHA\u2082DS\u2082-VASc score, which assesses various risk factors.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Rapid x descent is typically seen in conditions like constrictive pericarditis or cardiac tamponade but is not characteristic of atrial fibrillation. Option: C. Cannon \"a\" waves are seen in conditions like complete heart block or certain types of junctional rhythms, where atrial contraction coincides with ventricular contraction, causing a large a wave in the JVP. Option: D. Rapid y descent is also not typical in this context and does not directly relate to the findings in atrial fibrillation.</p>\n<p><strong>Extraedge:</strong></p><p>To measure jugular venous pressure (JVP), have the patient lie at a 30 to 45-degree angle, ensuring the neck is relaxed and supported. Position yourself on the right side of the patient for optimal visibility. Locate the sternoclavicular joint and measure the height of the highest point of pulsation in the external jugular vein above this reference point. Use a ruler or measuring tape held perpendicular to the plane of the sternal angle to record the height in centimeters. Ensure the JVP is assessed at the end of expiration for accuracy, and note any changes in the waveform that may indicate underlying cardiovascular issues.</p>\n<p><strong>Table:</strong></p><p>#MANTRA JVP waves and their clinical significance:- 'a' wave: \u25cf       Prominent in: \u25cb       Right ventricular hypertrophy (\u2191 resistance to filling) \u25cb       Pulmonary stenosis \u25cb       Pulmonary hypertension \u25cb       Tricuspid stenosis \u25cf       Absent in: \u25cb       Atrial fibrillation \u25cb       Tricuspid regurgitation (TR) Cannon 'a' wave: \u25cf       Seen in: \u25cb       Complete atrioventricular (AV) block \u25cb       Atrial flutter \u25cb       Ventricular extrasystole 'c' wave: \u25cf       Prominent in: Tricuspid regurgitation (TR) \u25cf       Absent in: Constrictive pericarditis 'v' wave: \u25cf       Prominent in: Constrictive pericarditis</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cae400e5",
      "audio": ""
    },
    {
      "text": "A patient presented to the casualty with chest pain and palpitations. His blood pressure was 130/90mmHg and pulse rate- 101 bpm. Echocardiography showed a collapse of the right atrium during diastole. What is the most appropriate management for this patient? NSAIDs- Non-steroidal anti-inflammatory drugs:",
      "options": [
        {
          "label": "A",
          "text": "NSAIDS",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pericardiocentesis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chest tube insertion or thoracotomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Steroids",
          "correct": false
        }
      ],
      "correct_answer": "B. Pericardiocentesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pericardiocentesis The patient with chest pain, palpitations, elevated pulse rate, and echocardiographic evidence of right atrial collapse during diastole likely has cardiac tamponade due to significant pericardial effusion. The most appropriate management for this condition is pericardiocentesis , a procedure that involves draining the excess fluid from the pericardial sac to alleviate pressure on the heart and restore proper hemodynamics.</p>\n<p><strong>Highyeild:</strong></p><p>Cardiac tamponade is a critical condition resulting from the accumulation of fluid, blood, or pus in the pericardial space, which surrounds the heart. This accumulation increases intrapericardial pressure, limiting the heart's ability to expand during diastole and resulting in impaired cardiac filling. Common etiologies include traumatic injury, malignancy, infectious processes (such as bacterial or viral infections), autoimmune diseases, and complications from cardiac surgery or pericarditis. The rapid accumulation of fluid often leads to acute tamponade, while slow accumulation may allow the heart to adapt somewhat, leading to chronic symptoms. Clinically, cardiac tamponade can present with a range of symptoms, including dyspnea, chest pain, tachycardia, and palpitations. Patients may exhibit signs of decreased cardiac output, such as hypotension, weakness, and altered mental status. The classic presentation, known as Beck's triad, includes hypotension, muffled heart sounds, and jugular venous distension due to increased central venous pressure. Other physical exam findings may include tachycardia, pulsus paradoxus (a drop in blood pressure during inspiration), and signs of fluid overload. Diagnosis is primarily achieved through echocardiography, which can visualize the presence of fluid in the pericardial space and assess its impact on cardiac chambers, often revealing signs such as right atrial and ventricular collapse during diastole. Other imaging modalities, such as chest X-ray or CT scan, may also be utilized but are less definitive. Management of cardiac tamponade typically involves urgent pericardiocentesis, a procedure in which a needle is inserted into the pericardial space to remove excess fluid and relieve pressure on the heart. This can be done under ultrasound guidance for accuracy and safety. In cases of recurrent tamponade or when pericardiocentesis is insufficient, surgical intervention may be required, such as a pericardial window, to provide a more permanent solution for fluid drainage. Long-term management may involve treating the underlying cause of the effusion, such as antibiotics for infection or chemotherapy for malignancy.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. NSAIDs : Nonsteroidal anti-inflammatory drugs may be used for pain relief or inflammation but do not address the urgent need to relieve cardiac tamponade. Option: C. Chest tube insertion or thoracotomy : These procedures are typically indicated for pleural effusions or significant thoracic injuries. In the case of cardiac tamponade, pericardiocentesis is a less invasive and more appropriate first step. Option: D. Steroids : While corticosteroids may be used in certain inflammatory conditions involving the pericardium, they do not provide immediate relief from the acute symptoms of cardiac tamponade and would not address the underlying fluid accumulation in the pericardial space.</p>\n<p><strong>Extraedge:</strong></p><p>Becks Triad:-</p>\n<p><strong>Table:</strong></p><p>#MANTRA Cardiac Tamponade v/s Constrictive Pericarditis: TAMPONADE CONSTRICTION Low cardiac output state Low cardiac output state JVP\u2191 JVP\u2191 RA: blunted y descent RA: rapid y descent Prom X descent Kussmaul's sign NO Kussmaul's sign Friedreich\u2019s sign Equalized diastolic pressures Equalized diastolic pressures Decreased heart sounds Pericardial \"knock\" P Paradoxus</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "caf6adb1",
      "audio": ""
    },
    {
      "text": "A 35-year-old female with a history of hypertension presents with palpitations, dyspnea, bilateral basal crackles and irregularly irregular pulse. ECG is given below. Which among the following management is least useful?",
      "options": [
        {
          "label": "A",
          "text": "Cardioversion in a hemodynamically unstable patient",
          "correct": false
        },
        {
          "label": "B",
          "text": "Direct oral anticoagulants",
          "correct": false
        },
        {
          "label": "C",
          "text": "Beta blockers is to be given for rate control if patient is intolerant to Calcium channel blockers",
          "correct": true
        },
        {
          "label": "D",
          "text": "IV digoxin for ventricular rate control",
          "correct": false
        }
      ],
      "correct_answer": "C. Beta blockers is to be given for rate control if patient is intolerant to Calcium channel blockers",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732270446561-QT60IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Beta blockers is to be given for rate control if patient is intolerant to Calcium channel blockers In this patient with palpitations, dyspnea, bilateral basal crackles, and an irregularly irregular pulse indicative of atrial fibrillation in the context of acute decompensated heart failure, the least useful management option is Beta blockers. This is because beta-blockers are negative inotropic agents that can worsen heart failure by decreasing cardiac output and exacerbating pulmonary congestion.</p>\n<p><strong>Highyeild:</strong></p><p>Acute decompensated heart failure (ADHF) is a syndrome characterized by the sudden worsening of heart failure symptoms, necessitating urgent medical attention. It occurs when the heart fails to maintain adequate blood flow to meet the body's demands, leading to congestion and reduced cardiac output. Common causes include myocardial infarction, uncontrolled hypertension, arrhythmias, acute valvular disease, myocarditis, and medication non-compliance. Non-cardiac factors, such as infections, anemia, hyperthyroidism, and renal dysfunction, can also precipitate ADHF. Patients with ADHF typically present with symptoms like dyspnea, which can be exacerbated by exertion or lying flat (orthopnea), paroxysmal nocturnal dyspnea, and peripheral edema. Other symptoms include fatigue, palpitations, and cough, often producing frothy, pink sputum in cases of pulmonary edema. Physical examination may reveal increased jugular venous pressure, bilateral crackles upon auscultation, an S3 gallop, and peripheral edema, reflecting fluid overload and poor perfusion. Diagnosis of ADHF is primarily clinical, relying on patient history and physical examination to assess fluid overload and low cardiac output. Diagnostic tools include electrocardiograms (ECG) to identify arrhythmias, chest X-rays to evaluate for pulmonary congestion, echocardiograms to assess cardiac function, and laboratory tests, including B-type natriuretic peptide (BNP) levels and renal function tests. Managemen t strategies for ADHF typically involve the use of diuretics to quickly alleviate fluid overload, vasodilators like nitroglycerin to reduce cardiac workload, and inotropic agents like dobutamine for patients with low cardiac output. Oxygen therapy may be provided to address hypoxia, and close monitoring in a hospital setting is crucial for assessing hemodynamic stability, vital signs, and electrolyte balance. Complications of ADHF can include acute pulmonary edema, cardiogenic shock, arrhythmias, and organ dysfunction due to inadequate perfusion.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Cardioversion in a hemodynamically unstable patient : This is appropriate and effective for restoring normal rhythm in unstable patients. Option: B. Direct oral anticoagulants : These are important for preventing thromboembolic events associated with AF, especially in the presence of heart failure. Option: D. IV digoxin for ventricular rate control : This can be useful in heart failure patients as it provides rate control with a positive inotropic effect, thus helping in symptom management.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Heart Failure algorithm:</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "954f4b9c",
      "audio": ""
    },
    {
      "text": "A patient suffered from RTA. After a few days, he had exaggerated right- sided extensor plantar reflex and knee jerk. What other finding would be seen?",
      "options": [
        {
          "label": "A",
          "text": "Ankle clonus in right foot",
          "correct": true
        },
        {
          "label": "B",
          "text": "Proprioception lost in left leg",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pain and temperature was lost in right leg",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fasciculations in right foot",
          "correct": false
        }
      ],
      "correct_answer": "A. Ankle clonus in right foot",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Ankle clonus in right foot The patient exhibiting exaggerated right-sided extensor plantar reflex and knee jerk suggests upper motor neuron involvement. In this context, the most likely additional finding would be ankle clonus in the right foot, as it is an upper motor neuron sign associated with increased reflex activity.</p>\n<p><strong>Highyeild:</strong></p><p>An upper motor neuron (UMN) lesion refers to damage to the neural pathways that convey impulses from the brain to the spinal cord, specifically affecting the motor cortex and its projections. These lesions can occur due to various conditions, including stroke, traumatic brain injury, multiple sclerosis, and spinal cord injuries. Features of Upper Motor Neuron Lesions: Motor Function Impairments: Patients typically exhibit weakness or paralysis (hemiparesis or quadriparesis) on the side opposite to the lesion (contralateral). This occurs because the motor pathways cross over at various points in the central nervous system. Increased Muscle Tone : Spasticity is common, characterized by increased resistance to passive movement, particularly when moving the joint quickly. This results from disrupted balance between excitatory and inhibitory influences on motor neurons. Exaggerated Reflexes: Hyperreflexia is observed, with heightened responses to reflex tests. For example, deep tendon reflexes (such as the knee jerk) may be exaggerated. Pathological Reflexes: Presence of abnormal reflexes, such as the Babinski sign (where the big toe extends upward when the sole of the foot is stroked), is indicative of UMN lesions. Clonus: Repetitive muscle contractions (clonus) can occur, particularly in the ankle, when the foot is dorsiflexed.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Proprioception loss typically indicates damage to the dorsal columns or peripheral nerves. In this case, we are focusing on right-sided upper motor neuron signs, which would not lead to loss of proprioception in the left leg. Option: C. Loss of pain and temperature sensation suggests damage to the spinothalamic tract, which does not correlate with the observed upper motor neuron signs. Option: D. Fasciculations indicate lower motor neuron involvement, typically due to anterior horn cell or peripheral nerve damage. In this case, we are looking for signs consistent with upper motor neuron lesions.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Upper Motor Neuron Lesion vs Lower Motor Neuron Lesion: UMN LMN Function Inhibitory effect on muscle stretch reflex Motor component of muscle reflex Type of paralysis Spastic Flacid DTR Hyperreflexia Hyporeflexia Muscle Tone Hypertonic \u25cf       Decorticate rigidity: lesion above midbrain \u25cf       Decerebrate rigidity: below midbrain Hypotonic Muscle Mass Disuse atrophy Wasting atrophy Fasciculations Nope PRESENT Babinski sign POSITIVE Nope Other reflexes Abdominal & Cremasteric LOST - - - - - Voluntary movement Decreased speed Lost =( Area of body involved Large area Small area</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7ee985ea",
      "audio": ""
    },
    {
      "text": "A male patient presents with headaches and visual disturbance. The patient had frontal bossing, thick palms, and soles, and gaping of central incisors. He is also hypertensive and diabetic. Which of the following statements is true about screening investigations done on this patient?",
      "options": [
        {
          "label": "A",
          "text": "GH levels <0.4 after 1 hour of 75 gm glucose tolerance test.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Single early morning fasting level of GH is used to establish the diagnosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Age specific IGF-1 levels are useful for screening",
          "correct": true
        },
        {
          "label": "D",
          "text": "GH levels are used to assess the severity of the condition",
          "correct": false
        }
      ],
      "correct_answer": "C. Age specific IGF-1 levels are useful for screening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Age specific IGF-1 levels are useful for screening IGF-1, produced in response to growth hormone, provides a stable measure of GH activity over time and is not subject to the fluctuations seen with GH levels. Elevated IGF-1 levels, particularly when adjusted for age, can indicate excess GH production and help in the early detection of acromegaly, making it a valuable screening tool in clinical practice.</p>\n<p><strong>Highyeild:</strong></p><p>Acromegaly is a hormonal disorder that occurs when the pituitary gland produces excess growth hormone (GH), usually due to a benign tumor known as a pituitary adenoma. This excess GH leads to an increase in insulin-like growth factor 1 (IGF-1) levels, causing progressive enlargement of bones and tissues. Cause : The most common cause of acromegaly is a GH-secreting pituitary adenoma. Other causes may include ectopic GH secretion from tumors in other organs (e.g., lung). Mechanism : Elevated GH stimulates the liver to produce IGF-1, which promotes cell growth and proliferation. This leads to the characteristic features of acromegaly, including bone growth and soft tissue hypertrophy. Clinical Features: Physical Changes: Enlarged hands and feet Coarsened facial features (e.g., enlarged nose, jaw, and brow) Frontal bossing (prominent forehead) Thickened skin and enlarged palms/soles Gaping of teeth due to jaw enlargement Systemic Symptoms: Headaches Visual disturbances (due to pressure on optic nerves) Hypertension Diabetes mellitus (due to insulin resistance) Joint pain and arthritis Diagnosis Biochemical Tests: IGF-1 Levels: Elevated IGF-1 levels are indicative of excess GH production and are age-adjusted for accuracy. Oral Glucose Tolerance Test (OGTT): GH levels do not suppress appropriately after glucose ingestion (normally should suppress <0.4 ng/mL). Imaging: MRI of the Pituitary Gland: Used to identify the presence of a pituitary adenoma or other lesions. Other Tests: Liver Function Tests: To assess IGF-1 effects on the liver. Thyroid Function Tests: To rule out thyroid dysfunction. Treatment Surgical Intervention: Transsphenoidal surgery is often the first-line treatment for pituitary adenomas. Medical Therapy: Somatostatin analogs (e.g., octreotide, lanreotide) reduce GH secretion. Growth hormone receptor antagonists (e.g., pegvisomant) block the effects of GH. Dopamine agonists (e.g., cabergoline) may also be effective in some cases. Radiation Therapy: Used in cases where surgery is not feasible or when residual tumor is present.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. In patients with acromegaly, GH levels typically do not suppress to <0.4 ng/mL after a glucose tolerance test. In fact, GH levels may remain elevated. Option: B. A single measurement of GH is not reliable for diagnosis since GH is pulsatile and can vary significantly. Option: D. While GH levels can be monitored, they are not primarily used to assess the severity of acromegaly; IGF-1 levels are more commonly utilized for this purpose.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Acromegaly is diagnosed primarily through the measurement of insulin-like growth factor 1 (IGF-1) levels, which are typically elevated due to excess growth hormone (GH). A glucose tolerance test is often performed, where GH levels do not suppress appropriately (typically remaining >0.4 ng/mL after a 75 g glucose load). Additionally, MRI imaging of the pituitary gland may be conducted to identify any adenomas or tumors causing the excess GH production. Symptoms such as enlarged hands and feet, facial changes, hypertension, and diabetes mellitus further support the diagnosis.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f93dbb0",
      "audio": ""
    },
    {
      "text": "Which of the following is most likely based on the lab values given? Blood pH: 7.3 Na+: 134 mEq/L K+: 2.8mEq/L CI: 113mEq/L HCO3-: 12mEq/L BUN: 3 mg/dL Creatinine: 0.6mg/dL Urinary pH: 9.4",
      "options": [
        {
          "label": "A",
          "text": "Type 1 renal tubular acidosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Type 2 renal tubular acidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Type 3 renal tubular acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "High Anion Gap Metabolic Acidosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Type 1 renal tubular acidosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Type 1 renal tubular acidosis Based on the lab values provided\u2014blood pH of 7.3, low potassium (K+) at 2.8 mEq/L, low bicarbonate (HCO3-) at 12 mEq/L, and an alkaline urinary pH of 9.4\u2014the most likely diagnosis is Type 1 renal tubular acidosis (RTA) . This condition is characterized by the inability of the distal tubules to excrete hydrogen ions, leading to metabolic acidosis with hypokalemia and alkaline urine.</p>\n<p><strong>Highyeild:</strong></p><p>Renal tubular acidosis (RTA) is a condition where the kidneys fail to properly acidify urine, leading to metabolic acidosis. It is classified into three types: Type 1 (Distal RTA) is marked by an inability to excrete hydrogen ions, resulting in alkaline urine and hypokalemia; Type 2 (Proximal RTA) involves impaired bicarbonate reabsorption, causing acidic urine and normal potassium levels; Type 3 RTA combines features of both. Feature Type Type 1 RTA (Distal RTA) Type 2 RTA (Proximal RTA) Type 3 RTA Location of Defect Distal nephron (collecting ducts) Proximal convoluted tubule Combined proximal and distal defects Serum Bicarbonate Level Low (<15 mEq/L) Low (often <15 mEq/L) Low (varies, often <15 mEq/L) Serum Potassium Level Low (hypokalemia, often <3.5 mEq/L) Normal (may be low in severe cases) Variable (can be normal, low, or high) Urinary pH Alkaline (>5.5) Acidic (<5.5) when serum bicarbonate is low; can be variable Variable (may be acidic or alkaline) Causes Autoimmune diseases (e.g., Sj\u00f6gren's syndrome), genetic disorders (e.g., primary hyperaldosteronism), medications (e.g., amphotericin B) Fanconi syndrome, carbonic anhydrase inhibitors, hereditary disorders (e.g., cystinosis) Rarely diagnosed; can be associated with specific genetic disorders or syndromes (e.g., Down syndrome) Clinical Features Metabolic acidosis, nephrocalcinosis, bone disease (osteomalacia), growth retardation in children Metabolic acidosis, hypophosphatemia, renal phosphate wasting, growth retardation Metabolic acidosis, symptoms of both proximal and distal RTA, variable presentations depending on severity Response to Acidosis Inability to acidify urine; urine remains alkaline Inability to reabsorb bicarbonate; urine can be acidified in acute acidosis Mixed response depending on severity; may show features of both types Calcium Handling Hypercalciuria due to increased calcium reabsorption Hypocalciuria due to renal phosphate wasting Variable, depending on the specific defects present Urine Anion Gap Positive or normal Positive or variable Variable Treatment Alkali therapy (e.g., sodium bicarbonate), potassium supplementation, treatment of underlying causes Potassium and phosphate supplements, bicarbonate therapy Treatment based on underlying cause; often requires a tailored approach</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Type 2 renal tubular acidosis : Typically associated with normal or high potassium levels and a more variable urinary pH (often acidic). Option: C. Type 3 renal tubular acidosis : This is a less commonly recognized type and usually includes elements of both proximal and distal RTA; the lab findings do not support this diagnosis. Option: D. High Anion Gap Metabolic Acidosis : This would be characterized by a low HCO3- and a high anion gap, often with signs of acute illness or renal failure, which does not align with the low BUN and creatinine levels seen here.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "73336616",
      "audio": ""
    },
    {
      "text": "What is the most likely cause of death in a patient suffering from Idiopathic pulmonary fibrosis?",
      "options": [
        {
          "label": "A",
          "text": "Pulmonary hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Respiratory failure",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lung carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "C. Respiratory failure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Respiratory failure In patients with idiopathic pulmonary fibrosis (IPF), the most likely cause of death is respiratory failure. This condition results from progressive lung scarring (fibrosis) that severely impairs gas exchange, leading to hypoxemia and respiratory distress. While complications such as pulmonary hypertension, pulmonary embolism, and an increased risk of lung carcinoma may occur in IPF patients, they are not the primary causes of mortality.</p>\n<p><strong>Highyeild:</strong></p><p>Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by the accumulation of scar tissue (fibrosis) in the lungs, leading to a decline in lung function. The term \"idiopathic\" indicates that the exact cause of the disease is unknown, although several risk factors and potential environmental triggers have been identified. In IPF, the normal healing process in the lungs is disrupted, leading to abnormal tissue repair and excessive collagen deposition. This results in thickening and stiffening of the lung interstitium, impairing gas exchange. The process often involves an initial inflammatory phase, followed by fibrosis that progressively worsens. Patients with IPF typically present with: Progressive Dyspnea: Shortness of breath that gradually worsens over time, especially during exertion. Chronic Dry Cough: A persistent, non-productive cough. Fatigue and Weight Loss: Patients may experience general fatigue and unintended weight loss. Clubbing of the Fingers: Digital clubbing (enlargement of the fingertips) is a common physical examination finding. Diagnosis of IPF is primarily based on clinical evaluation, imaging, and sometimes lung biopsy. High-Resolution Computed Tomography (HRCT): This imaging modality reveals characteristic patterns of fibrosis, such as reticular patterns and ground-glass opacities, with a basilar predominance. Pulmonary Function Tests (PFTs): These tests often show a restrictive pattern with decreased forced vital capacity (FVC) and total lung capacity (TLC). Exclusion of Other Causes: It is crucial to rule out other interstitial lung diseases and potential causes of pulmonary fibrosis, such as occupational exposures, autoimmune diseases, and drug-induced lung injury. There is currently no cure for IPF, but several management strategies aim to slow disease progression and alleviate symptoms: Antifibrotic Medications: Nintedanib and pirfenidone are approved for IPF and have been shown to slow the decline in lung function. Supportive Care: Supplemental oxygen therapy may be required as the disease progresses, along with pulmonary rehabilitation to improve physical function and quality of life. Lung Transplantation: In selected patients with advanced disease and deteriorating lung function, lung transplantation may be considered as a treatment option.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Pulmonary hypertension : While pulmonary hypertension can develop as a complication of Idiopathic pulmonary fibrosis due to hypoxemia and vascular remodeling, it is not the primary cause of death. It can contribute to worsening respiratory failure but is typically a secondary condition. Option: B. Pulmonary embolism : Although pulmonary embolism can occur in patients with Idiopathic pulmonary fibrosis, it is not the most common cause of death. The risk of embolism is generally lower compared to the progressive nature of respiratory failure due to Idiopathic pulmonary fibrosis. Option: D. Lung carcinoma : Patients with Idiopathic pulmonary fibrosis do have an increased risk of lung cancer; however, lung carcinoma is not the most common cause of death. The primary mortality in Idiopathic pulmonary fibrosis arises from the progressive respiratory failure caused by the fibrotic changes in the lungs.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Respiratory Failure types: TYPE I TYPE 2 TYPE 3 TYPE 4 Hypoxemic Respiratory Failure Definition: \u2193 PaO2+\u2193/nl CO2 Hypercapnic Respiratory Failure Definition: \u2193PaO2+\u2191 CO2 Peri-Operative Respiratory Failure Definition: A sub-type of Type 1 respiratory failure (\u2193PaO2+\u2193/nl CO2) occurring specifically in association with an operation, Shock with hypoperfusion Definition: A sub-type of Type 2 respiratory failure (\u2193PaO2+\u2191 CO2) occurring when metabolic (oxygen) demands exceed what can be provided. ETIOLOGIES ETIOLOGIES ETIOLOGIES ETIOLOGIES Alveolar hypoventilation \u2022 Obesity hypoventilation syndrome \u2022 Restrictive thoracic disorders \u2022 Central sleep apnea Low fraction of inspired oxygen \u2022 High Altitudes Diffusion defects \u2022 Emphysema \u2022 Interstitial lung disease Ventilation/perfusion (V/Q) mismatch \u2022 Acute respiratory distress syndrome \u2022 Chronic obstructive pulmonary disease \u2022 Congestive heart failure \u2022 Pulmonary embolism Right-to-left shunt \u2022 Severe pneumonia \u2022 Severe pulmonary edema \u2022 Arteriovenous malformation Inadequate respiration \u2022 Decreased central drive to breathe: Sedatives such as opiates, alcohol. benzodiazepines \u2022 CNS dysfunction: Stroke. Encephalopathy. Malignancy \u2022 Nerve diseases: Guillain-Barre syndrome, amyotrophic lateral sclerosis, botulism, tetanus, organophos- phate poisoning \u2022 Chest wall abnormalities: Kyphoscoliosis, obesity \u2022 Muscular dysfunction: Muscular dystrophy, dysfunction of the diaphragm Dysfunctional lung areas (unable to undergo gas exchange): \u2022 Tachypnea (\u2191 respiratory rate) Elevated Carbon Monoxide: \u2022 Increased metabolism: Fever. illness, exercise Impaired breathing mechanics \u2022 General (or residual) anesthesia \u2022 Supine (lying down) posture \u2022 Depressed cough reflex \u2022 Upper abdominal incisions \u2022 Ascites Suboptimal respiration \u2022 Airway secretions Conditions with higher-than- normal metabolic demand \u2022 Septic shock \u2022 Fever, illness \u2022 Exercise Reduced cardiac output \u2022 Cardiogenic shock: Heart failure, other cardiac dysfunction \u2022 Hypovolemic shock: Dehydration, blood loss</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93ef8fab",
      "audio": ""
    },
    {
      "text": "A person goes through routine tests while applying for a job. His ECG showed a PR interval of 0.21 sec. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "1st degree block",
          "correct": true
        },
        {
          "label": "B",
          "text": "Normal ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "2nd degree block",
          "correct": false
        },
        {
          "label": "D",
          "text": "Complete heart block",
          "correct": false
        }
      ],
      "correct_answer": "A. 1st degree block",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>1st degree block The ECG shows a PR interval of 0.21 seconds, which is prolonged, as a normal PR interval ranges from 0.12 to 0.20 seconds. This finding is indicative of first-degree AV block, where there is a delay in the conduction through the atrioventricular node, but all atrial impulses are still conducted to the ventricles. Thus, the correct diagnosis is first-degree block.</p>\n<p><strong>Highyeild:</strong></p><p>First-degree heart block, also known as first-degree AV (atrioventricular) block, is characterized by a prolonged PR interval on the electrocardiogram (ECG), specifically measuring greater than 0.20 seconds (200 ms). This condition reflects a delay in the conduction of electrical impulses through the AV node, but all atrial impulses are successfully transmitted to the ventricles, resulting in a normal QRS complex following each P wave. The ECG findings typically show a consistent PR interval that remains unchanged across the rhythm strip. Patients with first-degree heart block are often asymptomatic and may not experience any significant clinical issues; however, it can sometimes be associated with conditions such as myocardial ischemia, increased vagal tone, or the use of certain medications like beta-blockers or calcium channel blockers. While first-degree heart block is generally considered benign, it may be a marker for underlying cardiac conditions, especially if accompanied by symptoms or other ECG abnormalities. Management typically involves regular follow-up, particularly if the patient is asymptomatic, as it rarely progresses to more severe forms of heart block. Importantly, the prognosis is generally good, and many individuals with first-degree AV block lead normal, active lives without significant restrictions.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Normal ECG : A PR interval of 0.21 seconds is not within the normal range (0.12 to 0.20 seconds), indicating an abnormality rather than a normal ECG. Option: C. 2nd degree block : In second-degree AV block, there is typically a pattern of intermittent dropped QRS complexes (either type I or type II), which is not indicated by a constant prolonged PR interval of 0.21 seconds. Option: D. Complete heart block : In complete heart block (third-degree AV block), there is a total dissociation between atrial and ventricular activity, often resulting in varying PR intervals and usually a much wider QRS complex due to escape rhythms. A prolonged but consistent PR interval does not meet the criteria for complete heart block.</p>\n<p><strong>Extraedge:</strong></p><p>ECG values:- Component Characteristics Heart Rate 60-100 bpm PR Interval 0.12-0.20 sec QRS Interval 0.06-0.10 sec QT Interval Less than half of the R-R interval ST segment 0.08 sec</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "400665f7",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with hyperthermia, autonomic instability, confusion, hyperreflexia, muscle rigidity, and dilated pupils. The patient takes sertraline and was recently prescribed amitriptyline and sumatriptan for depression and migraines, respectively. Which medication is most likely to be effective in treating this patient's current condition?",
      "options": [
        {
          "label": "A",
          "text": "Cyproheptadine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diphenhydramine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nitroprusside",
          "correct": false
        }
      ],
      "correct_answer": "A. Cyproheptadine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Cyproheptadine The patient's presentation suggests serotonin syndrome , which can occur due to the use of serotonergic medications like sertraline, amitriptyline, and sumatriptan. Symptoms include hyperthermia, autonomic instability, confusion, hyperreflexia, muscle rigidity, and dilated pupils. In this case, the most effective treatment option would be Cyproheptadine. Cyproheptadine is an antihistamine with anti-serotonergic properties, making it a suitable choice for managing serotonin syndrome.</p>\n<p><strong>Highyeild:</strong></p><p>Serotonin syndrome is a potentially life-threatening condition resulting from excessive serotonergic activity in the central nervous system, typically triggered by the use of one or more serotonergic medications, such as SSRIs, SNRIs, tricyclic antidepressants, MAOIs, and certain opioids or migraine treatments. The condition arises from overstimulation of serotonin receptors, particularly 5-HT1A and 5-HT2A, leading to a range of symptoms classified into three categories: neuromuscular (hyperreflexia, myoclonus, muscle rigidity), autonomic (hyperthermia, diaphoresis, tachycardia, dilated pupils), and cognitive/behavioral (confusion, agitation, hallucinations). Diagnosis is primarily clinical and is based on the history of medication use and symptomatology, often utilizing the Hunter Serotonin Toxicity Criteria. Management involves immediate discontinuation of serotonergic agents, supportive care, and pharmacological treatment with cyproheptadine as a first-line option for mild to moderate cases, alongside benzodiazepines for sedation. While the prognosis is generally good with prompt treatment, untreated serotonin syndrome can lead to severe complications, including seizures and renal failure.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: B. Propranolol : Primarily used for cardiovascular issues and anxiety but not for serotonin syndrome. Option: C. Diphenhydramine : An antihistamine that does not have significant anti serotonergic effects. Option: D. Nitroprusside : Used for hypertensive emergencies and does not address serotonin syndrome.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6ea974ed",
      "audio": ""
    },
    {
      "text": "A 40-year-old female patient with a known case of myasthenia gravis on mycophenolate mofetil and pyridostigmine now presents with breathing difficulties. Her calcium levels were 13.5g/dl. What is the most likely cause for the increase in calcium?",
      "options": [
        {
          "label": "A",
          "text": "Small cell carcinoma of lung",
          "correct": false
        },
        {
          "label": "B",
          "text": "Drug induced hypercalcemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Parathyroid adenoma",
          "correct": true
        },
        {
          "label": "D",
          "text": "Adenocarcinoma lung",
          "correct": false
        }
      ],
      "correct_answer": "C. Parathyroid adenoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Parathyroid adenoma The most likely cause of hypercalcemia in this patient is a parathyroid adenoma . This is a benign tumor of the parathyroid gland that causes overproduction of parathyroid hormone, leading to increased calcium levels in the blood. While lung cancer can also cause hypercalcemia, it is less likely in this case due to the patient's history of myasthenia gravis. Drug-induced hypercalcemia is not a known side effect of mycophenolate mofetil or pyridostigmine.</p>\n<p><strong>Highyeild:</strong></p><p>Parathyroid adenoma is a benign tumor of the parathyroid glands, typically leading to hyperparathyroidism, characterized by excessive secretion of parathyroid hormone (PTH). The exact cause of parathyroid adenoma is often unknown. Genetic factors can play a role: Multiple Endocrine Neoplasia (MEN) syndrome: Types 1 and 2 can be associated with parathyroid adenomas. Familial isolated hyperparathyroidism. Pathophysiology- The adenoma leads to autonomous secretion of PTH, regardless of serum calcium levels. Elevated PTH causes: Increased calcium reabsorption from bones (osteoclastic activity). Increased intestinal absorption of calcium (via vitamin D activation). Increased renal tubular reabsorption of calcium and increased urinary excretion of phosphate. Symptoms of Hyperparathyroidism (often summarized as \"stones, bones, groans, and psychiatric overtones\"): Stones: Kidney stones due to hypercalcemia. Bones: Bone pain and fragility (osteitis fibrosa cystica). Groans: Abdominal pain, constipation, nausea, and peptic ulcers. Psychiatric Overtones: Depression, confusion, fatigue. Physical Examination: May show signs of hypercalcemia (e.g., altered mental status, muscle weakness). Diagnosis Laboratory Tests: Elevated serum calcium levels; Elevated PTH levels (inappropriately high in the presence of elevated calcium); Low serum phosphate (due to renal loss). Imaging: Ultrasound: Can identify enlarged parathyroid glands. Sestamibi Scintigraphy: Nuclear imaging to localize hyperfunctioning glands. CT/MRI: May be used in complex cases. Treatment Surgical Removal: The primary treatment is surgical excision of the adenoma. This is often curative. Monitoring: In asymptomatic cases with mild hypercalcemia, observation may be considered. Medical Management: Hydration and bisphosphonates may be used to manage hypercalcemia preoperatively.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Small cell carcinoma of lung: While lung cancer can cause hypercalcemia, it's less likely in this case due to the patient's existing myasthenia gravis, which is not typically associated with lung cancer. Option: B. Drug-induced hypercalcemia: Neither mycophenolate mofetil nor pyridostigmine are known to cause hypercalcemia as a side effect. Option: D. Adenocarcinoma lung: Similar to small cell carcinoma, lung cancer in general is less likely given the patient's existing condition.</p>\n<p><strong>Extraedge:</strong></p><p>Hypercalcemia algorithm :</p>\n<p><strong>Table:</strong></p><p>#MANTRA Feature Small Cell Lung Carcinoma Drug-Induced Hypercalcemia Parathyroid Adenoma Adenocarcinoma of the Lung Type Malignant neoplasm Condition caused by medication Benign tumor of the parathyroid glands Malignant neoplasm Origin Neuroendocrine cells Various medications (e.g., thiazides, lithium) Parathyroid gland Respiratory epithelium Calcium Levels Normal or slightly elevated Elevated calcium levels Elevated calcium levels Usually normal or slightly elevated Symptoms Cough, hemoptysis, weight loss Nausea, vomiting, confusion, dehydration, hypercalcemia symptoms (e.g., stones, bones, groans, psychiatric overtones) Hypercalcemia symptoms (e.g., stones, bones, groans, psychiatric overtones) Cough, hemoptysis, weight loss Diagnosis Histopathology, imaging Serum calcium and medication history Serum calcium, PTH levels, imaging Histopathology, imaging Treatment Chemotherapy, radiation Discontinuation of drug, hydration, bisphosphonates Surgery (parathyroidectomy) Surgery, chemotherapy, targeted therapy</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "949d12d3",
      "audio": ""
    },
    {
      "text": "A patient presented to the OPD with a temperature of 102\u00b0F, and a cough with foul-smelling sputum. On examination, clubbing is present. His chest X- ray is given below. What is the probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Pneumothorax",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pneumatocele",
          "correct": false
        },
        {
          "label": "C",
          "text": "Empyema",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung abscess",
          "correct": true
        }
      ],
      "correct_answer": "D. Lung abscess",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732270446838-QT100IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Lung abscess The patient's presentation of fever (102\u00b0F), cough with foul-smelling sputum, clubbing, and a chest X-ray revealing a cavity with a gas-fluid level is most indicative of a lung abscess. The foul-smelling sputum suggests an anaerobic infection, often related to aspiration, which is commonly associated with lung abscesses. Clubbing can occur in chronic pulmonary conditions, including abscesses, due to ongoing infection or hypoxia.</p>\n<p><strong>Highyeild:</strong></p><p>A lung abscess is a localized collection of pus within the lung tissue, usually resulting from an infection, commonly caused by anaerobic bacteria due to the aspiration of oropharyngeal contents. Risk factors include poor oral hygiene, alcoholism, seizures, and conditions that predispose individuals to aspiration. The clinical presentation typically includes symptoms such as fever, cough, and foul-smelling sputum, which are indicative of anaerobic infection. Patients may also experience pleuritic chest pain, dyspnea, and fatigue. Physical examination may reveal decreased breath sounds, crackles, or dullness on percussion over the affected area, along with signs of systemic infection like tachycardia and hypotension in severe cases. Chest imaging , particularly a chest X-ray or CT scan, usually reveals a cavitary lesion containing a gas-fluid level, suggesting the presence of necrotic tissue and pus. The walls of the abscess may be thickened, and surrounding consolidation may be present. Diagnosis is confirmed through imaging and sometimes by culture of sputum, bronchoalveolar lavage fluid, or pleural fluid if an associated empyema is suspected. Treatment primarily involves prolonged courses of antibiotics tailored to the likely pathogens, with common regimens including clindamycin or beta-lactam/beta-lactamase inhibitor combinations. In some cases, especially if the abscess is large or not responding to medical therapy, drainage via bronchoscopy or video-assisted thoracoscopic surgery (VATS) may be necessary. Complications can include the spread of infection to adjacent structures, the development of empyema, or bronchopleural fistula formation, underscoring the importance of early diagnosis and management.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Pneumothorax: Typically presents with sudden chest pain and shortness of breath; not associated with foul-smelling sputum. Option: B. Pneumatocele: Usually occurs in the context of a bacterial infection, often in children, but would not typically present with clubbing or foul sputum. Option: C. Empyema: This refers to pus in the pleural space; it may cause fever and cough, but the sputum is not typically foul-smelling.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe39762c",
      "audio": ""
    },
    {
      "text": "A young athlete presented with chest pain and dyspnea. His brother had passed away due to sudden cardiac death. He is diagnosed with HCM. A harsh systolic murmur is heard along the left sternal border. Which of the following will increase the murmur? HCM - Hypertrophic Cardiomyopathy",
      "options": [
        {
          "label": "A",
          "text": "Squatting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leaning forward with head down/up",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hand grip",
          "correct": false
        },
        {
          "label": "D",
          "text": "Valsalva",
          "correct": true
        }
      ],
      "correct_answer": "D. Valsalva",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Valsalva In hypertrophic cardiomyopathy (HCM), a harsh systolic murmur is typically heard at the left sternal border due to outflow obstruction from the hypertrophied myocardium. The intensity of this murmur increases during the Valsalva maneuver, which reduces venous return and subsequently enhances the outflow obstruction, making the murmur more pronounced.</p>\n<p><strong>Highyeild:</strong></p><p>Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder characterized by the abnormal thickening of the myocardium, particularly affecting the interventricular septum. This hypertrophy can lead to various clinical manifestations, including exertional dyspnea, chest pain, palpitations, syncope, and, in some cases, sudden cardiac death, particularly in young athletes. HCM is often inherited in an autosomal dominant manner, with mutations in genes encoding sarcomeric proteins, such as myosin heavy chain, troponin T, and myosin-binding protein C. The pathological thickening of the heart muscle can obstruct the outflow tract from the left ventricle to the aorta, resulting in dynamic left ventricular outflow tract (LVOT) obstruction during systole. Patients with HCM may be asymptomatic, but those who present with symptoms typically experience: Dyspnea on exertion: Due to increased myocardial oxygen demand and impaired diastolic filling. Chest pain: Often due to myocardial ischemia. Palpitations: Resulting from arrhythmias, which can include atrial fibrillation and ventricular tachycardia. Syncope: Often occurs during physical activity, attributed to arrhythmias or obstructive physiology. Family history: A significant factor, as HCM can run in families and is a leading cause of sudden cardiac death in young individuals. A characteristic feature of HCM is the presence of a systolic ejection murmur, best heard at the left sternal border. This murmur is caused by: Dynamic LVOT obstruction: The thickened septum and the anterior motion of the mitral valve leaflet create turbulence during systole, resulting in a harsh systolic murmur. Murmur Changes with Maneuvers:- The intensity of the murmur can vary with different physiological maneuvers due to changes in preload and afterload: Valsalva Maneuver: Increases the murmur intensity by reducing venous return and exacerbating outflow obstruction. Standing: Similar to Valsalva, it reduces preload, thus increasing the murmur. Squatting: Increases venous return and systemic vascular resistance, leading to a decrease in murmur intensity. Hand Grip: Increases systemic vascular resistance (afterload), which also typically decreases the murmur intensity.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Squatting: Increases venous return, which usually decreases the murmur. Option: B. Leaning forward with head down/up: This can sometimes enhance the murmur but not as significantly as Valsalva. Option: C. Hand grip: Increases systemic vascular resistance (afterload) and typically decreases the murmur intensity.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Changes in Murmurs: Murmurs Inspiration & Expiration Increased Preload (Rapid squatting, Passive leg raising) Decreased Preload (Valsalva, Standing) Increased Afterload (Handgrip) Decreased Afterload (Amyl nitrite) Most murmurs \u2191 Right-sided murmurs on inspiration; \u2191Left-sided murmurs on expiration \u2191Increase \u2193Decrease Stenotic murmurs (except MS): \u2193 Regurgitant murmurs: \u2191 Stenotic murmurs (except MS): \u2191 Regurgitant murmurs :  \u2193 AS \u2191on expiration \u2191Increase \u2193Decrease \u2193Decrease \u2191Increase MVP No effect \u2193Decrease with later onset click \u2191Increase with early onset click \u2193Decrease with later onset click \u2191 Increase with early onset click HOCM No effect \u2193Decrease \u2191Increase \u2193Decrease \u2191Increase</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96d4e24e",
      "audio": ""
    },
    {
      "text": "A patient gives a history of epigastric pain radiating to the back for five days. Lab investigations show that amylase and lipase are elevated five times the normal values. Two litres of saline was administered in 24 hours to the patient. He also gave a history of consumption of alcohol. Given below is the chest X-ray of the patient. What is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Aspiration pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-cardiogenic pulmonary edema",
          "correct": true
        },
        {
          "label": "C",
          "text": "Miliary tuberculosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bilateral pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "B. Non-cardiogenic pulmonary edema",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732270446955-QT120IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Non-cardiogenic pulmonary edema The most probable diagnosis for the patient with epigastric pain radiating to the back, elevated amylase and lipase levels, a history of alcohol consumption, and chest X-ray findings suggestive of ARDS is non-cardiogenic pulmonary edema. This condition is likely a complication of acute pancreatitis, which can lead to systemic inflammatory responses and fluid accumulation in the lungs.</p>\n<p><strong>Highyeild:</strong></p><p>Non-cardiogenic pulmonary edema (NCPE) is a condition characterized by the accumulation of fluid in the alveoli and interstitial spaces of the lungs, not primarily due to heart failure or cardiac causes. This type of pulmonary edema can arise from various pathological processes and often presents with acute respiratory distress. NCPE can result from several factors, including: Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS): Direct lung injury (e.g., pneumonia, aspiration, toxic inhalation) or indirect lung injury (e.g., sepsis, pancreatitis) can lead to NCPE. Infections: Severe pneumonia, especially viral (e.g., influenza) or bacterial infections, can trigger NCPE. Trauma: Physical injury to the chest or lung tissue can cause inflammatory responses leading to fluid accumulation. Aspiration: Inhalation of gastric contents can irritate lung tissue, resulting in NCPE. Toxic Substances: Exposure to toxic gases (e.g., chlorine, ammonia) or certain medications can damage alveolar-capillary membranes, causing edema. Fluid Overload: Rapid intravenous fluid administration, particularly in patients with compromised lung function, can contribute to NCPE. Other Conditions: Conditions like pancreatitis, renal failure, or systemic inflammatory response syndrome (SIRS) can also lead to NCPE through mechanisms of increased permeability of the alveolar-capillary membrane. In NCPE, the integrity of the alveolar-capillary membrane is compromised, leading to increased permeability. This allows fluid, proteins, and inflammatory cells to leak into the interstitial space and alveoli, disrupting normal gas exchange. The accumulation of fluid impairs oxygen diffusion and can result in hypoxemia. The non-cardiogenic nature distinguishes NCPE from cardiogenic pulmonary edema, where fluid accumulation is due to elevated hydrostatic pressures resulting from heart failure. Patients with NCPE often exhibit: Dyspnea: Shortness of breath that can be rapid in onset. Cough: May produce pink, frothy sputum. Tachypnea: Increased respiratory rate. Hypoxemia: Low blood oxygen levels may require supplemental oxygen. Cyanosis: Bluish discoloration of the skin, indicating severe hypoxia. Diagnosis of NCPE involves: Clinical Assessment: History of recent illness, trauma, or risk factors (e.g., pancreatitis, drug use). Imaging: Chest X-ray may show bilateral infiltrates, ground-glass opacities, and air bronchograms. CT scans can provide more detailed views of fluid distribution. Exclusion of Cardiogenic Causes: Assessing cardiac function through echocardiography or measuring pulmonary capillary wedge pressure to rule out heart failure. Management strategies for NCPE include: Oxygen Therapy: To address hypoxemia. Mechanical Ventilation: In cases of severe respiratory failure, non-invasive ventilation (CPAP/BiPAP) or intubation may be necessary. Treating Underlying Causes: Managing the primary condition (e.g., antibiotics for pneumonia, addressing pancreatitis) is crucial. Fluid Management: Careful monitoring and restriction of fluid intake to avoid exacerbating edema.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Aspiration pneumonia: While possible, the history does not specifically indicate aspiration, and the primary issue appears to be related to pancreatitis. Option: C. Miliary tuberculosis: Typically presents with different clinical features and imaging findings, and there's no history supporting this diagnosis. Option: D. Bilateral pulmonary embolism: Would present differently and is less likely given the context of acute pancreatitis and ARDS.</p>\n<p><strong>Extraedge:</strong></p><p>ARDS New Global Definition 2023 new definition criteria Classification Mild Moderate Severe Time to installation Up to seven days - known risk factor(s) Pulmonary edema Not explained by cardiogenic edema or intravascular volume overload Radiologic features Bilateral infiltrates on chest X-ray or CT or lung ultrasound (by a trained professional) (not explained by nodules, pleural effusion or atelectasis) Hypoxemia PaO 2 /FIO 2 ** 201-300 with NIV/CPAP PEEP \u2265 5* or HFNO > 30l/min 101-200 com PEEP \u2265 5 \u2264 100 com PEEP \u2265 5 Hypoxemia SpO 2 /FIO 2 < 315 with SpO 2 \u2264 97%</p>\n<p><strong>Table:</strong></p><p>#MANTRA Feature Non-Cardiogenic Pulmonary Edema (NCPE) Cardiogenic Pulmonary Edema (CPE) Etiology Direct lung injury, infections, aspiration, toxic exposure, fluid overload, acute lung injury Heart failure, myocardial infarction, valve disorders, fluid overload due to cardiac dysfunction Pathophysiology Increased permeability of the alveolar-capillary membrane, leading to fluid accumulation Increased hydrostatic pressure in pulmonary circulation due to heart failure, causing fluid leakage into alveoli Chest X-ray Findings Bilateral infiltrates, ground-glass opacities, may show air bronchograms Bilateral perihilar opacities, Kerley B lines, \"bat wing\" pattern of edema Symptoms Acute dyspnea, cough with pink frothy sputum, hypoxemia, tachypnea Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, cough with pink frothy sputum Treatment Oxygen therapy, mechanical ventilation, treating underlying cause Diuretics, nitrates, positive inotropes, addressing underlying heart condition</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0688893",
      "audio": ""
    },
    {
      "text": "A 35-year-old female presented with complaints of fever for 5 days and there were no signs of meningitis. MRI with diffusion-weighted and contrast are shown. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Tuberculoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Toxoplasmosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glioma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Brain abscess",
          "correct": true
        }
      ],
      "correct_answer": "D. Brain abscess",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732270446960-QT121IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Brain abscess The most likely diagnosis for this 35-year-old female with fever, MRI findings of ring enhancement, restricted diffusion on DWI, and marked perilesional edema is a brain abscess. This is characterized by a necrotic center surrounded by an inflammatory capsule, which causes the ring enhancement and significant edema.</p>\n<p><strong>Highyeild:</strong></p><p>A brain abscess is a localized collection of pus within the brain tissue, usually resulting from bacterial or fungal infections that can arise from hematogenous spread, contiguous infections (like sinusitis or otitis media), or direct trauma. Patients typically present with symptoms such as fever, severe headache, neurological deficits, altered mental status, and seizures, often alongside signs of increased intracranial pressure. Diagnosis is primarily achieved through imaging studies, particularly MRI, which reveals a ring-enhancing lesion with a central necrotic area and surrounding edema, often accompanied by restricted diffusion on DWI due to high cellularity. Management involves antibiotic or antifungal therapy tailored to the suspected pathogen and may require surgical intervention for drainage of the abscess, especially if it is large or causing significant symptoms. Without prompt treatment, brain abscesses can lead to serious complications, including seizures, increased intracranial pressure, and potential neurological deficits; however, with timely intervention, many patients can achieve substantial recovery.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Tuberculomas can show ring enhancement and associated edema but usually have a more gradual onset of symptoms and often demonstrate less restricted diffusion on DWI. They also tend to appear as multiple lesions rather than a single abscess. Option: B. Toxoplasmosis typically presents as multiple ring-enhancing lesions, particularly in immunocompromised patients (e.g., HIV). While they can show restricted diffusion, it is generally less pronounced than that seen in a brain abscess, and the lesions usually have a more homogeneous appearance. Option: C. Gliomas generally do not present with well-defined ring enhancement like a brain abscess. They often show infiltrative growth patterns and may have necrotic centers, but the edema is usually less marked in the early stages, and restricted diffusion is not as prominent as in abscesses.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Feature Tuberculoma Toxoplasmosis Glioma Brain Abscess Etiology Mycobacterium tuberculosis Toxoplasma gondii Neoplastic (various types) Bacterial or fungal infections Clinical Presentation Fever, headache, seizures, focal neurological deficits Fever, headache, confusion, seizures Headache, seizures, neurological deficits, personality changes Fever, headache, neurological deficits, seizures Imaging Findings Ring-enhancing lesions on MRI, often multiple, with surrounding edema Multiple ring-enhancing lesions on MRI, typically with surrounding edema Heterogeneous mass with possible necrosis and edema; may show contrast enhancement Ring-enhancing lesion with a central necrotic area and significant surrounding edema; restricted diffusion on DWI Diffusion Imaging Typically shows mild diffusion restriction Usually mild diffusion restriction Variable, often not restricted Shows restricted diffusion due to high cellularity CSF Analysis May show lymphocytic pleocytosis and positive acid-fast bacilli Often normal, but may show increased antibodies against Toxoplasma Malignant cells may be present, depending on tumor type Elevated white blood cell count, may show bacteria/fungi if cultured Treatment Anti-tuberculosis therapy (e.g., isoniazid, rifampicin) Pyrimethamine and sulfadiazine or clindamycin; supportive care Surgical resection, radiation, chemotherapy depending on type and grade Antibiotics or antifungal therapy and surgical drainage</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f5927ce",
      "audio": ""
    },
    {
      "text": "A patient presented with right upper and lower limb weakness with left sided facial nerve palsy and left sided horizontal gaze palsy. What is the probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Millard- Gubler syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Benedikt's syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Foville syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Locked in syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Foville syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Foville syndrome The patient's presentation of right-sided weakness, left-sided facial palsy, and left-sided gaze palsy strongly suggests Foville syndrome, a condition arising from a lesion in the lower pontine tegmentum, often caused by a stroke affecting the paramedian branches of the basilar artery.</p>\n<p><strong>Highyeild:</strong></p><p>Foville syndrome is a rare neurological condition associated with lesions in the brainstem, specifically affecting the pons. It is characterized by a combination of cranial nerve deficits and motor disturbances. Here are the key details: Foville syndrome typically arises from: Vascular lesions: Ischemic strokes or hemorrhages in the pons. Tumors: Growths affecting the pons or adjacent structures. Infections: Conditions like multiple sclerosis or infections affecting the brainstem. The syndrome is characterized by a combination of symptoms, including: Cranial Nerve Palsies: Facial Nerve (CN VII): Weakness or paralysis of facial muscles on the affected side (facial droop). Abducens Nerve (CN VI): Impaired lateral eye movement, leading to diplopia (double vision). Trigeminal Nerve (CN V): Loss of sensation in the face, as well as potential weakness in the muscles of mastication. Motor Dysfunction: Hemiparesis: Weakness on the opposite side of the body due to corticospinal tract involvement. Ataxia: Lack of coordination and balance due to involvement of the cerebellar pathways. Dysarthria: Speech difficulties due to weakness of the muscles involved in speech. Pathophysiology- The syndrome results from damage to specific pathways in the pons, including: Corticospinal tracts: Leading to motor weakness. Cranial nerve nuclei: Resulting in cranial nerve palsies. Cerebellar pathways: Contributing to ataxia. Diagnosis is based on: Clinical Evaluation: Assessment of neurological deficits and symptoms. Imaging Studies: MRI or CT scans to identify lesions in the pons or brainstem. Management of Foville syndrome focuses on: Treating the underlying cause: Addressing vascular issues, tumors, or infections. Rehabilitation: Physical therapy, occupational therapy, and speech therapy to improve motor functions and speech. Symptomatic treatment: Pain management and addressing specific deficits.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Millard-Gubler syndrome: This syndrome primarily involves ipsilateral facial nerve palsy and contralateral hemiparesis. It does not typically involve horizontal gaze palsy, which is a key feature of the patient's presentation. Option: B. Benedikt's syndrome: This syndrome involves ipsilateral oculomotor nerve palsy and contralateral hemiparesis. The patient's presentation involves facial nerve palsy, not oculomotor nerve palsy. Option: D. Locked-in syndrome: This syndrome involves quadriplegia and an inability to speak, with preserved consciousness. The patient in this case can move their limbs, indicating that locked-in syndrome is not the correct diagnosis.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Syndrome Causes Clinical Features Key Characteristics Foville Syndrome Vascular lesions, tumors, infections Facial nerve palsy, abducens nerve palsy, hemiparesis, ataxia Involvement of cranial nerves VII and VI; motor weakness Millard-Gubler Syndrome Pontine hemorrhage, ischemic strokes Ipsilateral facial weakness, contralateral hemiparesis, dysarthria Involves CN VII and corticospinal tract; affects facial muscle control Locked-In Syndrome Basilar artery occlusion, brainstem strokes Quadriplegia, preserved consciousness, facial sparing, dysarthria Intact cognitive function but inability to move; communication via blinking Weber Syndrome Midbrain lesions affecting the cerebral peduncles Contralateral hemiparesis, ipsilateral oculomotor nerve palsy Involves CN III; contralateral motor deficits Benedikt Syndrome Midbrain lesions Contralateral hemiparesis, ipsilateral oculomotor nerve palsy, ataxia Involves CN III and red nucleus; presents with ataxia AICA Syndrome Vertebral artery occlusion, AICA infarcts Vertigo, hearing loss, facial weakness, ataxia Affects anterior inferior cerebellar artery distribution</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1de13177",
      "audio": ""
    },
    {
      "text": "A 36-year-old girl presented with tremors and weight loss. Her ophthalmic examination shows the following findings. Identify the true statement regarding the following condition:",
      "options": [
        {
          "label": "A",
          "text": "No association with HLA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Medial rectus is the first muscle to be involved",
          "correct": false
        },
        {
          "label": "C",
          "text": "The muscles and connective tissue around the eye shares similar antigen with diseased organ",
          "correct": true
        },
        {
          "label": "D",
          "text": "More common in males",
          "correct": false
        }
      ],
      "correct_answer": "C. The muscles and connective tissue around the eye shares similar antigen with diseased organ",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732270446985-QT131IMG1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>The muscles and connective tissue around the eye shares similar antigen with diseased organ The true statement regarding the condition described, likely Graves' disease, is that the muscles and connective tissue around the eye share similar antigens with the diseased organ. Graves' disease is an autoimmune hyperthyroid condition commonly associated with exophthalmos, where antibodies produced against thyroid antigens can also target the retro-orbital tissues, leading to inflammation and swelling.</p>\n<p><strong>Highyeild:</strong></p><p>Graves' disease is an autoimmune disorder that results in overactivity of the thyroid gland (hyperthyroidism). It is the most common cause of hyperthyroidism and is characterized by the production of antibodies against the thyroid-stimulating hormone receptor (TSHR), leading to increased synthesis and release of thyroid hormones (T3 and T4). The disease predominantly affects women, with a female-to-male ratio of approximately 5:1, and commonly presents between the ages of 30 and 50. The hallmark of Graves' disease is the presence of thyroid-stimulating immunoglobulins (TSIs), which mimic the action of TSH, causing the thyroid gland to grow and produce excessive amounts of thyroid hormones. This hyperfunction can lead to various systemic effects, including increased metabolism, weight loss, heat intolerance, and nervousness. Symptoms of Graves' disease can include: Hyperthyroid symptoms: Fatigue, weight loss, heat intolerance, increased appetite, tremors, and palpitations. Ophthalmopathy: One of the distinctive features is Graves' ophthalmopathy (thyroid eye disease), which may present as exophthalmos (protrusion of the eyes), eyelid retraction, diplopia (double vision), and vision changes due to inflammation of the extraocular muscles. Dermopathy: In some cases, patients may develop pretibial myxedema, characterized by thickening and swelling of the skin, typically over the shins. Diagnosis is typically confirmed through blood tests that show elevated levels of free T4 and suppressed TSH. The presence of TSI can be assessed, along with thyroid-stimulating antibodies. Radioactive iodine uptake tests may also be conducted to evaluate the function of the thyroid gland. Management options for Graves' disease include: Antithyroid medications: Drugs like methimazole and propylthiouracil inhibit thyroid hormone synthesis. Radioactive iodine therapy: This treatment destroys overactive thyroid tissue and is often considered for patients who are intolerant to medication or have a recurrent disease. Surgery: Thyroidectomy may be performed in cases of large goiter, suspicion of malignancy, or when other treatments are ineffective. Symptomatic treatment: Beta-blockers can help manage symptoms such as palpitations and tremors.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. No association with HLA : This statement is false. Graves' disease has been associated with specific HLA haplotypes, particularly HLA-DR3. Option: B. Medial rectus is the first muscle to be involved : While the medial rectus muscle can be involved in thyroid eye disease, the inferior rectus is often affected first. Option: D. More common in males : This statement is false. Graves' disease is more common in females than in males, with a ratio of approximately 5:1.</p>\n<p><strong>Extraedge:</strong></p><p>Thyroid Function Test Algorithm:</p>\n<p><strong>Table:</strong></p><p>#MANTRA Eye Signs of Graves\u2019 disease: Von Graefe\u2019s sign-lid lag on downgaze Dalrymple's sign-lid retraction Stellwag's sign-incomplete & infrequent blinking Grove sign-resistance to pulling the retracted upper lid Boston sign-jerky movements of lid on down gaze Gellineck's sign-abnormal pigmentation of upper lid Gifford's sign-difficulty in everting the upper lid</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f6593289",
      "audio": ""
    },
    {
      "text": "A patient came with a history of dyspnea. His CT scan is shown below. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Mediastinal mass invading vascular structures",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thrombosed arch of aorta",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mediastinal mass with fat and calcification",
          "correct": true
        },
        {
          "label": "D",
          "text": "This is characteristic of mediastinal Hydatid cyst",
          "correct": false
        }
      ],
      "correct_answer": "C. Mediastinal mass with fat and calcification",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1732270447001-QT137IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Mediastinal mass with fat and calcification The presence of -62 HU (Hounsfield Units) intensity suggests that there is fat content in the mediastinal mass. In addition, calcification indicates that the mass is likely to be a benign process, which aligns with the characteristics of certain mediastinal masses, such as teratomas or lipomas, which can contain fat and calcifications.</p>\n<p><strong>Highyeild:</strong></p><p>A mediastinal mass refers to an abnormal growth located in the mediastinum, the central compartment of the thoracic cavity situated between the lungs. This area contains vital structures such as the heart, great vessels, trachea, esophagus, and lymph nodes. Mediastinal masses can be classified based on their location (anterior, middle, or posterior mediastinum) and can arise from various tissues, including thymic, lymphatic, neurogenic, and connective tissues. Common causes include tumors (benign and malignant), cysts, infections, and vascular anomalies. Pathologically, mediastinal masses can exhibit diverse features depending on their type. Thymomas often show a mixture of thymic epithelial cells and lymphocytes, with varying degrees of atypia and encapsulation. Lymphomas typically present with sheets of atypical lymphoid cells, which may be of B-cell or T-cell origin, often accompanied by necrosis and a variable inflammatory background. Germ cell tumors, such as teratomas, can contain differentiated tissues like fat, hair, and calcifications, reflecting their origin from pluripotent germ cells. Neurogenic tumors, like schwannomas or neurofibromas, can exhibit spindle cell morphology and often arise from nerve sheaths. Imaging studies , particularly chest X-rays and CT scans, play a crucial role in diagnosis. CT scans can reveal the size, shape, density, and characteristics of the mass, such as the presence of fat, calcifications, or enhancement patterns after contrast administration. Treatment options depend on the nature of the mass, its size, and symptoms, ranging from careful observation to surgical resection, chemotherapy, or radiation therapy. Symptoms associated with mediastinal masses can include dyspnea, cough, chest pain, and systemic symptoms like weight loss or fever, depending on the mass's effect on surrounding structures. Early diagnosis and intervention are essential to prevent complications and improve outcomes.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Mediastinal mass invading vascular structures : While mediastinal masses can invade vascular structures, the specific mention of fat and calcification leans more towards a benign entity. Option B: Thrombosed arch of aorta : This condition would not typically present with fat or calcification on imaging. Option: D. This is characteristic of mediastinal hydatid cyst : Hydatid cysts usually present with fluid density and may show peripheral calcification but do not typically have fat content.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f3d84e8",
      "audio": ""
    },
    {
      "text": "A patient after RTA underwent ileal resection. He presents with fatigue, which of the following will not be seen? RTA - Road Traffic Accident",
      "options": [
        {
          "label": "A",
          "text": "Cyto-nuclear dys-synchrony",
          "correct": false
        },
        {
          "label": "B",
          "text": "Microcytic hypochromic anemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Romberg's sign positive",
          "correct": false
        },
        {
          "label": "D",
          "text": "Subacute combined degeneration",
          "correct": false
        }
      ],
      "correct_answer": "B. Microcytic hypochromic anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Microcytic hypochromic anemia In this patient with ileal resection, fatigue is likely due to vitamin B12 deficiency, as the terminal ileum is the main absorption site for B12. This deficiency leads to neurological issues, such as a positive Romberg's sign and subacute combined degeneration of the spinal cord. It also causes cyto-nuclear dys-synchrony seen in megaloblastic anemia. Microcytic hypochromic anemia, usually linked to iron deficiency, is not expected in this scenario.</p>\n<p><strong>Highyeild:</strong></p><p>Vitamin B12 deficiency , commonly caused by inadequate dietary intake, malabsorption, or specific medical conditions, has significant implications for both hematological and neurological health. This vitamin is essential for DNA synthesis, red blood cell formation, and various metabolic processes, including the conversion of homocysteine to methionine and the metabolism of odd-chain fatty acids and certain amino acids. A deficiency can lead to macrocytic anemia, characterized by large, immature red blood cells, causing symptoms like fatigue, weakness, and pallor. Neurological manifestations are also prominent, including peripheral neuropathy (numbness, tingling, or burning sensations in the extremities), gait disturbances, and balance issues, often leading to a positive Romberg's sign . Cognitive changes, such as memory loss and confusion, may occur, and physical signs like glossitis (inflammation of the tongue) and angular cheilitis (cracking at the corners of the mouth) can indicate deficiency. Blood tests typically reveal macrocytic anemia alongside elevated homocysteine and methylmalonic acid levels, which are sensitive markers of deficiency. The accumulation of homocysteine due to impaired metabolism can increase cardiovascular disease risk, while elevated methylmalonic acid indicates disrupted fatty acid metabolism. Moreover, vitamin B12 is crucial for the formation of the myelin sheath surrounding nerve fibers; its deficiency can disrupt myelination, resulting in neurological symptoms. If left untreated, B12 deficiency can lead to irreversible nerve damage and cognitive decline, emphasizing the importance of early diagnosis and treatment through supplementation or dietary modifications to restore metabolic function and prevent complications.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Cyto-nuclear dys-synchrony : This term describes a characteristic finding in megaloblastic anemia due to B12 deficiency, where nuclear maturation is delayed relative to cytoplasmic development. This mismatch is common in B12 deficiency, so it\u2019s expected. Option: C. Romberg's sign positive : B12 deficiency can impair proprioception and balance due to damage to the dorsal columns of the spinal cord. Romberg\u2019s sign, which tests proprioception, may be positive as a result. Option: D. Subacute combined degeneration : B12 deficiency can lead to subacute combined degeneration of the spinal cord, affecting both the dorsal and lateral columns. This results in sensory and motor deficits, making it a characteristic finding in B12 deficiency cases.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Absorption site for Iron, Vitamin B12 and Folate:</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82b415ce",
      "audio": ""
    },
    {
      "text": "A young man had a history of jaundice and raised HBsAg levels a year back. On follow-up now, he has normal levels of liver enzymes. His current profile is shown in the image. What is the diagnosis for his current condition?",
      "options": [
        {
          "label": "A",
          "text": "Chronic HepB with HBeAg negative",
          "correct": false
        },
        {
          "label": "B",
          "text": "Resolved infection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic HepB with HBeAg positive",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acute HepB",
          "correct": false
        }
      ],
      "correct_answer": "C. Chronic HepB with HBeAg positive",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1734330464060-photos-1732270447079-QT154IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Chronic HepB with HBeAg positive The diagnosis is Chronic Hepatitis B with HBeAg positive. This is indicated by the patient\u2019s HBsAg positivity for over six months, confirming chronic infection. The presence of HBeAg suggests ongoing viral replication, though normal liver enzyme levels imply he may be in the immune-tolerant phase, where there\u2019s minimal liver damage despite active virus presence.</p>\n<p><strong>Highyeild:</strong></p><p>Hepatitis B virus (HBV) infection is a viral infection that primarily affects the liver and can lead to acute or chronic liver disease. The course of the infection, progression, and clinical status of a patient with Hepatitis B can be monitored by testing for specific markers in the blood. Phases of Hepatitis B Infection: Acute Hepatitis B: Initial phase of infection, lasting up to six months. Most adults can clear the virus, but a small percentage may progress to chronic Hepatitis B. Chronic Hepatitis B: Persistent infection for more than six months. Divided into phases based on immune response and viral activity. Hepatitis B Markers HBsAg (Hepatitis B Surface Antigen): Active infection, either acute or chronic. If HBsAg is positive for over six months, it indicates chronic Hepatitis B. In resolved cases, HBsAg clears from the blood. Anti-HBs (Hepatitis B Surface Antibody): Immunity to Hepatitis B, either from vaccination or recovery from past infection. Confirms immunity and no ongoing infection. HBeAg (Hepatitis B e Antigen): High levels of viral replication and infectivity. Often found during active phases of the virus; in chronic cases, indicates high infectivity. Anti-HBe (Antibody to Hepatitis B e Antigen): Low or no viral replication. Can indicate the transition to a less infectious state, especially in chronic infection. Anti-HBc (Total Core Antibody): Exposure to Hepatitis B virus. Appears during both acute and chronic infection phases and remains for life. Used to differentiate between past exposure and immunity from vaccination. IgM Anti-HBc: Specifically suggests recent infection (acute phase or acute-on-chronic flare). HBV DNA (Hepatitis B Viral DNA): The level of viral replication and the actual viral load in the blood. Essential for assessing the severity of the infection, effectiveness of treatment, and deciding on therapy.</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option: A. Chronic Hepatitis B with HBeAg negative : This would imply the patient is not producing the HBeAg, suggesting a lower level of viral replication. However, the patient is currently HBeAg positive, indicating active viral replication, so this option is incorrect. Option: B. Resolved infection : If the infection were resolved, HBsAg would no longer be detectable. The persistence of HBsAg indicates ongoing infection, so this does not fit. Option: D. Acute Hepatitis B : Acute Hepatitis B is characterized by a recent infection, usually lasting less than six months. Since this patient had HBsAg detected a year ago, the infection is chronic, not acute.</p>\n<p><strong>Extraedge:</strong></p><p>Hepatitis Viruses:- Virus Type Transmission Incubation Period Risk of Chronicity Symptoms Diagnosis Vaccine Availability Treatment Hepatitis A (HAV) Fecal-oral (contaminated food/water) 2-6 weeks None Jaundice, fatigue, nausea, fever Anti-HAV IgM antibody Yes Supportive care Hepatitis B (HBV) Blood, sexual contact, mother-to-child 6 weeks-6 months 5-10% in adults, higher in infants Jaundice, abdominal pain, fatigue HBsAg, HBeAg, anti-HBc, HBV DNA Yes Antivirals for chronic cases Hepatitis C (HCV) Blood (mostly IV drug use, transfusion) 2 weeks-6 months 75-85% Often asymptomatic, fatigue, liver damage Anti-HCV, HCV RNA No Antivirals for chronic cases Hepatitis D (HDV) Requires HBV co-infection (bloodborne) 3-7 weeks (requires HBV) High if co-infection with HBV Similar to HBV; more severe symptoms Anti-HDV, HDV RNA No (HBV vaccine indirectly protects) Treat HBV; limited options for HDV Hepatitis E (HEV) Fecal-oral (contaminated water) 2-10 weeks Rare in healthy individuals Jaundice, fatigue, liver inflammation Anti-HEV IgM antibody, HEV RNA No Supportive care</p>\n<p><strong>Table:</strong></p><p>#MANTRA Hepatitis B Serology markers: HBsAg Anti-HBc IgM anti-HBc Anti-HBs Interpretation Negative Negative Negative No HBV infection, susceptible Negative Negative > 10 IU/L Immune, due to HBV vaccination Negative Positive > 10 IU/L Past/resolved infection Negative Positive <10 IU/L Isolated anti-HBc*, probably past infection Positive** Negative Probably false-positive HBsAg or early infection A Positive** Positive ++ Acute infection Positive** Positive +/- Chronic infection***</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "355ea88d",
      "audio": ""
    }
  ]
}